Carol A. Tamminga - Publications

Affiliations: 
Department of Psychiatry University of Texas Southwestern Medical Center, Dallas, TX, United States 

479 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Clementz BA, Parker DA, Trotti RL, McDowell JE, Keedy SK, Keshavan MS, Pearlson GD, Gershon ES, Ivleva EI, Huang LY, Hill SK, Sweeney JA, Thomas O, Hudgens-Haney M, Gibbons RD, ... Tamminga CA, et al. Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium. Schizophrenia Bulletin. PMID 34409449 DOI: 10.1093/schbul/sbab090  1
2021 Parker DA, Trotti RL, McDowell JE, Keedy SK, Hill SK, Gershon ES, Ivleva EI, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA. Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. The American Journal of Psychiatry. appiajp202120071043. PMID 34407624 DOI: 10.1176/appi.ajp.2021.20071043  1
2021 Eskridge CLM, Hochberger WC, Kaseda ET, Lencer R, Reilly JL, Keedy SK, Keefe RSE, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA, Hill SK. Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders. Schizophrenia Research. 236: 54-60. PMID 34392106 DOI: 10.1016/j.schres.2021.07.036  1
2021 Eum S, Hill SK, Alliey-Rodriguez N, Stevenson JM, Rubin LH, Lee AM, Mills LJ, Reilly JL, Lencer R, Keedy SK, Ivleva E, Keefe RSE, Pearlson GD, Clementz BA, Tamminga CA, et al. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 34145405 DOI: 10.1038/s41386-021-01057-8  1
2021 Martin-Cook K, Palmer L, Thornton L, Rush AJ, Tamminga CA, Ibrahim HM. Setting Measurement-Based Care in Motion: Practical Lessons in the Implementation and Integration of Measurement-Based Care in Psychiatry Clinical Practice. Neuropsychiatric Disease and Treatment. 17: 1621-1631. PMID 34079260 DOI: 10.2147/NDT.S308615  1
2021 Türközer HB, Ivleva EI, Palka J, Clementz BA, Shafee R, Pearlson GD, Sweeney JA, Keshavan MS, Gershon ES, Tamminga CA. Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. Schizophrenia Bulletin. PMID 33693883 DOI: 10.1093/schbul/sbab013  1
2021 Berto S, Fontenot MR, Seger S, Ayhan F, Caglayan E, Kulkarni A, Douglas C, Tamminga CA, Lega BC, Konopka G. Gene-expression correlates of the oscillatory signatures supporting human episodic memory encoding. Nature Neuroscience. PMID 33686299 DOI: 10.1038/s41593-021-00803-x  1
2021 Huang LY, Jackson BS, Rodrigue AL, Tamminga CA, Gershon ES, Pearlson GD, Keshavan MS, Keedy SS, Hill SK, Sweeney JA, Clementz BA, McDowell JE. Antisaccade error rates and gap effects in psychosis syndromes from bipolar-schizophrenia network for intermediate phenotypes 2 (B-SNIP2). Psychological Medicine. 1-10. PMID 33622437 DOI: 10.1017/S003329172000478X  1
2021 Brown JA, Jackson BS, Burton CR, Hoy JE, Sweeney JA, Pearlson GD, Keshavan MS, Keedy SS, Gershon ES, Tamminga CA, Clementz BA, McDowell JE. Reduced White Matter Microstructure in Bipolar Disorder with and without Psychosis. Bipolar Disorders. PMID 33550654 DOI: 10.1111/bdi.13055  1
2021 Frässle S, Harrison SJ, Heinzle J, Clementz BA, Tamminga CA, Sweeney JA, Gershon ES, Keshavan MS, Pearlson GD, Powers A, Stephan KE. Regression dynamic causal modeling for resting-state fMRI. Human Brain Mapping. PMID 33539625 DOI: 10.1002/hbm.25357  1
2021 Seitz-Holland J, Cetin-Karayumak S, Wojcik JD, Lyall A, Levitt J, Shenton ME, Pasternak O, Westin CF, Baxi M, Kelly S, Mesholam-Gately R, Vangel M, Pearlson G, Tamminga CA, Sweeney JA, et al. Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study. Molecular Psychiatry. PMID 33483689 DOI: 10.1038/s41380-021-01018-z  1
2021 Zhu X, Zhou B, Pattni R, Gleason K, Tan C, Kalinowski A, Sloan S, Fiston-Lavier AS, Mariani J, Petrov D, Barres BA, Duncan L, Abyzov A, Vogel H, ... ... Tamminga CA, et al. Machine learning reveals bilateral distribution of somatic L1 insertions in human neurons and glia. Nature Neuroscience. PMID 33432196 DOI: 10.1016/J.Euroneuro.2019.07.158  1
2020 Kelly S, Guimond S, Pasternak O, Lutz O, Lizano P, Cetin-Karayumak S, Sweeney JA, Pearlson G, Clementz BA, McDowell JE, Tamminga CA, Shenton ME, Keshavan MS. White matter microstructure across brain-based biotypes for psychosis - findings from the bipolar-schizophrenia network for intermediate phenotypes. Psychiatry Research. Neuroimaging. 308: 111234. PMID 33385763 DOI: 10.1016/j.pscychresns.2020.111234  1
2020 Lizano P, Lutz O, Xu Y, Rubin LH, Paskowitz L, Lee AM, Eum S, Keedy SK, Hill SK, Reilly JL, Wu B, Tamminga CA, Clementz BA, Pearlson GD, Gershon ES, et al. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Molecular Psychiatry. PMID 33060818 DOI: 10.1038/s41380-020-00914-0  1
2020 Tamminga CA, Clementz BA, Pearlson G, Keshavan M, Gershon ES, Ivleva EI, McDowell J, Meda SA, Keedy S, Calhoun VD, Lizano P, Bishop JR, Hudgens-Haney M, Alliey-Rodriguez N, Asif H, et al. Biotyping in psychosis: using multiple computational approaches with one data set. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32979849 DOI: 10.1038/s41386-020-00849-8  1
2020 Anderson MP, Quinton R, Kelly K, Falzon A, Halladay A, Schumann CM, Hof PR, Tamminga CA, Hare CK, Amaral DG. Autism BrainNet. Archives of Pathology & Laboratory Medicine. PMID 32960953 DOI: 10.5858/arpa.2020-0164-RA  1
2020 Seitz J, Cetin-Karayumak S, Lyall A, Pasternak O, Baxi M, Vangel M, Pearlson G, Tamminga C, Sweeney J, Clementz B, Schretlen D, Viher PV, Stegmayer K, Walther S, Lee J, et al. Investigating Sexual Dimorphism of Human White Matter in a Harmonized, Multisite Diffusion Magnetic Resonance Imaging Study. Cerebral Cortex (New York, N.Y. : 1991). PMID 32851404 DOI: 10.1093/Cercor/Bhaa220  1
2020 Hochberger WC, Eskridge CLM, Bishop JR, Reilly JL, Rubin LH, Keedy S, Gershon ES, Tamminga CA, Pearlson GD, Ragozzino M, Keshavan MS, Sweeney JA, Hill SK. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives. Schizophrenia Research. PMID 32829984 DOI: 10.1016/J.Schres.2020.08.005  1
2020 Gotra MY, Hill SK, Gershon ES, Tamminga CA, Ivleva EI, Pearlson GD, Keshavan MS, Clementz BA, McDowell JE, Buckley PF, Sweeney JA, Keedy SK. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophrenia Research. PMID 32674921 DOI: 10.1016/J.Schres.2020.06.033  1
2020 Herms EN, Bishop JR, Okuneye VT, Tamminga CA, Keshavan MS, Pearlson GD, Clementz BA, McDowell JE, Ivleva EI, Gershon ES, Sweeney JA, Keedy SK. No connectivity alterations for striatum, default mode, or salience network in association with self-reported antipsychotic medication dose in a large chronic patient group. Schizophrenia Research. PMID 32624351 DOI: 10.1016/J.Schres.2020.06.017  1
2020 Clementz BA, Trotti RL, Pearlson GD, Keshavan MS, Gershon ES, Keedy SK, Ivleva EI, McDowell JE, Tamminga CA. Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32600898 DOI: 10.1016/J.Bpsc.2020.03.011  1
2020 Fountoulakis KN, Moeller HJ, Kasper S, Tamminga C, Yamawaki S, Kahn R, Tandon R, Correll CU, Javed A. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. Cns Spectrums. 1-75. PMID 32594935 DOI: 10.1017/S1092852920001546  1
2020 Zeng V, Lizano P, Bolo NR, Lutz O, Brady R, Ivleva EI, Dai W, Clementz B, Tamminga C, Pearlson G, Keshavan M. Altered Cerebral Perfusion in Bipolar Disorder: A pCASL MRI Study. Bipolar Disorders. PMID 32583570 DOI: 10.1111/Bdi.12966  1
2020 Lutz O, Lizano P, Mothi SS, Zeng V, Hegde RR, Hoang DT, Henson P, Brady R, Tamminga CA, Pearlson G, Clementz BA, Sweeney JA, Keshavan MS. Do neurobiological differences exist between paranoid and non-paranoid schizophrenia? Findings from the bipolar schizophrenia network on intermediate phenotypes study. Schizophrenia Research. PMID 32507376 DOI: 10.1016/J.Schres.2020.02.011  1
2020 Kane JM, Vanover KE, Durgam S, Davis R, Satlin A, Rowe W, Mates S, Tamminga C. 185 The Safety and Tolerability of Lumateperone 42 mg for the Treatment of Schizophrenia: A Pooled Analysis of 3 Randomized Placebo-Controlled Trials. Cns Spectrums. 25: 316-317. PMID 32331042 DOI: 10.1017/S1092852920001005  1
2020 Issler O, van der Zee YY, Ramakrishnan A, Wang J, Tan C, Loh YE, Purushothaman I, Walker DM, Lorsch ZS, Hamilton PJ, Peña CJ, Flaherty E, Hartley BJ, Torres-Berrío A, Parise EM, ... ... Tamminga CA, et al. Sex-Specific Role for the Long Non-coding RNA LINC00473 in Depression. Neuron. PMID 32304628 DOI: 10.1016/J.Neuron.2020.03.023  1
2020 Pignatelli M, Tejeda HA, Barker DJ, Bontempi L, Wu J, Lopez A, Palma Ribeiro S, Lucantonio F, Parise EM, Torres-Berrio A, Alvarez-Bagnarol Y, Marino RAM, Cai ZL, Xue M, Morales M, ... Tamminga CA, et al. Cooperative synaptic and intrinsic plasticity in a disynaptic limbic circuit drive stress-induced anhedonia and passive coping in mice. Molecular Psychiatry. PMID 32161361 DOI: 10.1038/S41380-020-0686-8  1
2020 Perez JM, Berto S, Gleason K, Ghose S, Tan C, Kim TK, Konopka G, Tamminga CA. Hippocampal subfield transcriptome analysis in schizophrenia psychosis. Molecular Psychiatry. PMID 32152472 DOI: 10.1038/S41380-020-0696-6  1
2020 Bannai D, Lizano P, Kasetty M, Lutz O, Zeng V, Sarvode S, Kim LA, Hill S, Tamminga C, Clementz B, Gershon E, Pearlson G, Miller JB, Keshavan M. Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: A preliminary study. Psychiatry Research. Neuroimaging. 299: 111061. PMID 32145500 DOI: 10.1016/J.Pscychresns.2020.111061  1
2020 Asif H, Alliey-Rodriguez N, Keedy S, Tamminga CA, Sweeney JA, Pearlson G, Clementz BA, Keshavan MS, Buckley P, Liu C, Neale B, Gershon ES. GWAS significance thresholds for deep phenotyping studies can depend upon minor allele frequencies and sample size. Molecular Psychiatry. PMID 32066829 DOI: 10.1038/S41380-020-0670-3  1
2020 Hudgens-Haney ME, Clementz BA, Ivleva EI, Keshavan MS, Pearlson GD, Gershon ES, Keedy SK, Sweeney JA, Gaudoux F, Bunouf P, Canolle B, Tonner F, Gatti-McArthur S, Tamminga CA. Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis. Schizophrenia Bulletin. PMID 32043133 DOI: 10.1016/J.Biopsych.2020.02.327  1
2020 Dudek KA, Dion-Albert L, Lebel M, LeClair K, Labrecque S, Tuck E, Ferrer Perez C, Golden SA, Tamminga C, Turecki G, Mechawar N, Russo SJ, Menard C. Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression. Proceedings of the National Academy of Sciences of the United States of America. PMID 31974313 DOI: 10.1073/Pnas.1914655117  1
2020 Blackburn KM, Ivleva EI, Weir RA, Kim M, Hopkins SC, Hudgens-Haney ME, Keedy SK, Gershon ES, Sweeney JA, Keshavan MS, Pearlson GD, Clementz BA, Tamminga CA, Vernino S. NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP). Schizophrenia Research. PMID 31952910 DOI: 10.1016/J.Schres.2020.01.004  1
2020 Correll CU, Davis RE, Weingart M, Saillard J, O'Gorman C, Kane JM, Lieberman JA, Tamminga CA, Mates S, Vanover KE. Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial. Jama Psychiatry. PMID 31913424 DOI: 10.1001/Jamapsychiatry.2019.4379  1
2020 Zeng V, Lizano P, Hegde R, Lutz O, Hoang D, Adhan I, Nisenson M, Raymond N, Lai M, Bannai D, Tamminga C, Clementz B, Pearlson G, Sweeney J, Keshavan M. Thalamic Nuclei Reductions Across the Psychosis Spectrum: A BSNIP Study Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.881  1
2020 Mendizabal I, Berto S, Usui N, Toriumi K, Chatterjee P, Douglas C, Huh I, Jeong H, Layman T, Tamminga C, Preuss T, Konopka G, Yi S. Cell-Type Specific Epigenetic Links to Schizophrenia Risk in Control and Patients Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.176  1
2019 Stan AD, Tamminga CA, Han K, Kim JB, Padmanabhan J, Tandon N, Hudgens-Haney ME, Keshavan MS, Clementz BA, Pearlson GD, Sweeney JA, Gibbons RD. Associating Psychotic Symptoms with Altered Brain Anatomy in Psychotic Disorders Using Multidimensional Item Response Theory Models. Cerebral Cortex (New York, N.Y. : 1991). PMID 31813988 DOI: 10.1093/Cercor/Bhz285  1
2019 Zhang W, Du L, Keedy SK, Ivleva EI, Eum S, Yao L, Tamminga CA, Clementz BA, Keshavan MS, Pearlson GD, Gershon ES, Bishop JR, Gong Q, Lui S, Sweeney JA. Brain gray matter network organization in psychotic disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31812151 DOI: 10.1038/S41386-019-0586-2  1
2019 Massa N, Owens AV, Harmon W, Bhattacharya A, Ivleva EI, Keedy S, Sweeney JA, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Duncan E. Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort. Schizophrenia Research. PMID 31796306 DOI: 10.1016/J.Schres.2019.11.013  1
2019 Brakemeier S, Sprenger A, Meyhöfer I, McDowell JE, Rubin LH, Hill SK, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Keedy SS, Sweeney JA, Clementz BA, Lencer R. Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder - Findings from the PARDIP study. Bipolar Disorders. PMID 31721386 DOI: 10.1111/Bdi.12865  1
2019 Berto S, Mendizabal I, Usui N, Toriumi K, Chatterjee P, Douglas C, Tamminga CA, Preuss TM, Yi SV, Konopka G. Accelerated evolution of oligodendrocytes in the human brain. Proceedings of the National Academy of Sciences of the United States of America. PMID 31712436 DOI: 10.1073/Pnas.1907982116  1
2019 Trotti RL, Parker DA, Sabatinelli D, Tamminga CA, Gershon ES, Keedy SK, Keshavan MS, Pearlson GD, Sweeney JA, McDowell JE, Clementz BA. Electrophysiological correlates of emotional scene processing in bipolar disorder. Journal of Psychiatric Research. 120: 83-90. PMID 31634753 DOI: 10.1016/J.Jpsychires.2019.10.005  1
2019 Dai W, Chen M, Duan W, Zhao L, Bolo NR, Tamminga C, Clementz BA, Pearlson GD, Alsop DC, Keshavan M. Abnormal Perfusion Fluctuation and Perfusion Connectivity in Bipolar Disorder Measured by Dynamic Arterial Spin Labeling. Bipolar Disorders. PMID 31630476 DOI: 10.1111/Bdi.12856  1
2019 Tamminga CA, Clementz BA. Biological fingerprints for psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31558770 DOI: 10.1038/S41386-019-0505-6  1
2019 Alliey-Rodriguez N, Grey TA, Shafee R, Asif H, Lutz O, Bolo NR, Padmanabhan J, Tandon N, Klinger M, Reis K, Spring J, Coppes L, Zeng V, Hegde RR, Hoang DT, ... ... Tamminga C, et al. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Translational Psychiatry. 9: 230. PMID 31530798 DOI: 10.1038/S41398-019-0564-9  1
2019 Cetin-Karayumak S, Di Biase MA, Chunga N, Reid B, Somes N, Lyall AE, Kelly S, Solgun B, Pasternak O, Vangel M, Pearlson G, Tamminga C, Sweeney JA, Clementz B, Schretlen D, et al. White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study. Molecular Psychiatry. PMID 31511636 DOI: 10.1038/S41380-019-0509-Y  1
2019 Öngür D, Carter CS, Gur RE, Perkins D, Sawa A, Seidman LJ, Tamminga C, Huggins W, Hamilton C. Common Data Elements for National Institute of Mental Health-Funded Translational Early Psychosis Research. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31439493 DOI: 10.1016/J.Bpsc.2019.06.009  1
2019 Ji L, Meda SA, Tamminga CA, Clementz BA, Keshavan MS, Sweeney JA, Gershon ES, Pearlson GD. Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches. Schizophrenia Research. PMID 31439419 DOI: 10.1016/J.Schres.2019.07.015  1
2019 Mendizabal I, Berto S, Usui N, Toriumi K, Chatterjee P, Douglas C, Huh I, Jeong H, Layman T, Tamminga CA, Preuss TM, Konopka G, Yi SV. Cell type-specific epigenetic links to schizophrenia risk in the brain. Genome Biology. 20: 135. PMID 31288836 DOI: 10.1186/S13059-019-1747-7  1
2019 Bobilev AM, Perez JM, Tamminga CA. Molecular alterations in the medial temporal lobe in schizophrenia. Schizophrenia Research. PMID 31227207 DOI: 10.1016/J.Schres.2019.06.001  1
2019 Lizano P, Lutz O, Ling G, Lee AM, Eum S, Bishop JR, Kelly S, Pasternak O, Clementz B, Pearlson G, Sweeney JA, Gershon E, Tamminga C, Keshavan M. Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum. The American Journal of Psychiatry. appiajp201918070825. PMID 31164007 DOI: 10.1176/Appi.Ajp.2019.18070825  1
2019 Ji JL, Diehl C, Schleifer C, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA, Hill SK, Pearlson G, Yang G, Creatura G, Krystal JH, Repovs G, Murray J, Winkler A, et al. Schizophrenia Exhibits Bi-directional Brain-Wide Alterations in Cortico-Striato-Cerebellar Circuits. Cerebral Cortex (New York, N.Y. : 1991). PMID 31157363 DOI: 10.1093/Cercor/Bhy306  1
2019 Parker DA, Hamm JP, McDowell JE, Keedy SK, Gershon ES, Ivleva EI, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA. Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophrenia Research. PMID 31080153 DOI: 10.1016/J.Schres.2019.04.014  1
2019 Nucifora LG, MacDonald ML, Lee BJ, Peters ME, Norris AL, Orsburn BC, Yang K, Gleason K, Margolis RL, Pevsner J, Tamminga CA, Sweet RA, Ross CA, Sawa A, Nucifora FC. Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia. The American Journal of Psychiatry. appiajp201918070864. PMID 31055969 DOI: 10.1176/Appi.Ajp.2019.18070864  1
2019 Reininghaus U, Böhnke JR, Chavez-Baldini U, Gibbons R, Ivleva E, Clementz BA, Pearlson GD, Keshavan MS, Sweeney JA, Tamminga CA. Transdiagnostic dimensions of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 67-76. PMID 30600629 DOI: 10.1002/Wps.20607  1
2019 Nucifora L, MacDonald M, Lee B, Peters M, Norris A, Orsburn BO, Gleason K, Yang K, Margolis R, Pevsner J, Tamminga C, Sweet R, Ross C, Sawa A, Nucifora F. O2.3. Increased Protein Insolubility In Brains From A Subset Of Patients With Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz021.187  1
2019 Alliey N, Rubin D, Asif H, Hudgens-Haney M, Clementz BA, Pearlson GD, Keshavan MS, Sweeney JA, Tamminga C, Keedy S, Gershon E. T47Brain Angiogenesis Inhibitor Gene Is Associated With Modifications Of Event Response Potentials In Psychosis European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.08.246  1
2019 Urban A, Zhu X, Zhou B, Sloan S, Pattni R, Fiston-Lavier A, Snyder M, Petrov D, Abyzov A, Vaccarino F, Barres B, Vogel H, Tamminga C, Levinson D. Sa94Machine Learning Analysis Of Ultra-Deep Whole-Genome Sequencing In Human Brain Reveals Somatic Genomic Retrotransposition In Glia As Well As In Neurons European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.08.316  1
2019 Lutz O, Hegde R, Henson P, Hoang J, Zeng V, Tamminga C, Clementz B, Pearlson G, Sweeney JA, Lizano P, Keshavan M. S162. Widespread Amygdala Nuclei Reductions Across the Psychosis Spectrum and in Their First-Degree Relatives: A BSNIP Study Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.913  1
2019 Nucifora L, MacDonald M, Lee B, Peters M, Norris A, Orsburn B, Yang K, Gleason K, Margolis R, Pevsner J, Tamminga C, Sweet R, Ross C, Sawa A, Nucifora F. F168. Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.705  1
2019 Lizano P, Kasetty M, Zeng R, Wang J, Diaz D, Lutz O, Zeng V, Sweeney JA, Clementz B, Tamminga C, Keshavan M. T176. Examining Retinal Nerve Fiber Layer Thickness and Microvascular Abnormalities in Psychosis With Swept Source OCT and OCT-A Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.499  1
2019 Lutz O, Hegde R, Henson P, Hoang J, Zeng V, Tamminga C, Clementz B, Pearlson G, Sweeney J, Lizano P, Keshavan M. T173. Structural Amygdala Nuclei Abnormalities Distinguish Neurobiologically Derived Biotypes With Psychosis Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.496  1
2018 Clementz BA, Sweeney JA, Hamm JP, Ivleva EI, Ethridge LE, Pearlson GD, Keshavan MS, Tamminga CA. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. Focus (American Psychiatric Publishing). 16: 225-236. PMID 32015710 DOI: 10.1176/appi.focus.16207  1
2018 Rubin LH, Li S, Yao L, Keedy SK, Reilly JL, Hill SK, Bishop JR, Sue Carter C, Pournajafi-Nazarloo H, Drogos LL, Gershon E, Pearlson GD, Tamminga CA, Clementz BA, Keshavan MS, et al. Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia. Schizophrenia Research. 202: 173-179. PMID 30539769 DOI: 10.1093/Schbul/Sbx021.131  1
2018 Jiang C, Lin WJ, Labonté B, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR. VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30504797 DOI: 10.1038/S41386-018-0277-4  1
2018 Freedman R, Lewis DA, Michels R, Pine DS, Rush AJ, Schultz SK, Tamminga CA, Glass O. 2018 in Review. The American Journal of Psychiatry. 175: 1163-1166. PMID 30501415 DOI: 10.1176/Appi.Ajp.2018.18091065  1
2018 Lizano P, Lutz O, Ling G, Padmanabhan J, Tandon N, Sweeney J, Tamminga C, Pearlson G, Ruaño G, Kocherla M, Windemuth A, Clementz B, Gershon E, Keshavan M. VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study. Translational Psychiatry. 8: 215. PMID 30310054 DOI: 10.1038/S41398-018-0271-Y  1
2018 Tamminga CA, Ivleva EI. Using Brain-Based Phenotyping to Improve Discovery in Psychiatry. Jama Psychiatry. PMID 30304331 DOI: 10.1001/Jamapsychiatry.2018.2451  1
2018 Lencer R, Yao L, Reilly JL, Keedy SK, McDowell JE, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Clementz BA, Lui S, Sweeney JA. Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders. Human Brain Mapping. PMID 30260540 DOI: 10.1002/Hbm.24362  1
2018 van der Doef TF, Domingo SZ, Jacobs GE, Drevets WC, Marston HM, Nathan PJ, Tome MB, Tamminga CA, van Gerven JMA, Kas MJH. New approaches in psychiatric drug development. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30056086 DOI: 10.1016/J.Euroneuro.2018.06.006  0.01
2018 Segev A, Yanagi M, Scott D, Southcott SA, Lister JM, Tan C, Li W, Birnbaum SG, Kourrich S, Tamminga CA. Reduced GluN1 in mouse dentate gyrus is associated with CA3 hyperactivity and psychosis-like behaviors. Molecular Psychiatry. PMID 30038231 DOI: 10.1038/S41380-018-0124-3  1
2018 Mothi SS, Sudarshan M, Tandon N, Tamminga C, Pearlson G, Sweeney J, Clementz B, Keshavan MS. Machine learning improved classification of psychoses using clinical and biological stratification: Update from the bipolar-schizophrenia network for intermediate phenotypes (B-SNIP). Schizophrenia Research. PMID 29807804 DOI: 10.1016/J.Schres.2018.04.037  1
2018 Rodrigue AL, McDowell JE, Tandon N, Keshavan MS, Tamminga CA, Pearlson GD, Sweeney JA, Gibbons RD, Clementz BA. Multivariate Relationships Between Cognition and Brain Anatomy Across the Psychosis Spectrum. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 29759822 DOI: 10.1016/J.Bpsc.2018.03.012  1
2018 Freedman R, Brown AS, Cannon TD, Druss BG, Earls FJ, Escobar J, Hurd YL, Lewis DA, López-Jaramillo C, Luby J, Mayberg HS, Moffitt TE, Oquendo M, Perlis RH, Pine DS, ... ... Tamminga CA, et al. Can a Framework Be Established for the Safe Use of Ketamine? The American Journal of Psychiatry. appiajp201818030290. PMID 29656666 DOI: 10.1176/Appi.Ajp.2018.18030290  1
2018 Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Kalapurakkel S, Weiner DJ, Gur RE, Keefe RSE, Hill SK, Bishop JR, Clementz BA, Tamminga CA, Gershon ES, Pearlson GD, et al. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Translational Psychiatry. 8: 78. PMID 29643358 DOI: 10.1038/S41398-018-0124-8  1
2018 Tamminga CA, McMahon L. Welcome. Biological Psychiatry. 83: A10. PMID 29636123 DOI: 10.1016/j.biopsych.2018.02.1170  0.01
2018 Labonté B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, Scarpa JR, Moy G, Loh YE, Cahill M, Lorsch ZS, Hamilton PJ, Calipari ES, Hodes GE, Issler O, ... ... Tamminga C, et al. Corrigendum: Sex-specific transcriptional signatures in human depression. Nature Medicine. 24: 525. PMID 29634684 DOI: 10.1038/Nm0418-525D  1
2018 Abush H, Ghose S, Van Enkevort EA, Clementz BA, Pearlson GD, Sweeney JA, Keshavan MS, Tamminga CA, Ivleva EI. Associations between adolescent cannabis use and brain structure in psychosis. Psychiatry Research. PMID 29628270 DOI: 10.1016/J.Pscychresns.2018.03.008  1
2018 Akinhanmi MO, Biernacka JM, Strakowski SM, McElroy SL, Balls Berry JE, Merikangas KR, Assari S, McInnis MG, Schulze TG, LeBoyer M, Tamminga C, Patten C, Frye MA. Racial disparities in bipolar disorder treatment and research: a call to action. Bipolar Disorders. PMID 29527766 DOI: 10.1111/Bdi.12638  0.01
2018 Amaral DG, Anderson MP, Ansorge O, Chance S, Hare C, Hof PR, Miller M, Nagakura I, Pickett J, Schumann C, Tamminga C. Autism BrainNet: A network of postmortem brain banks established to facilitate autism research. Handbook of Clinical Neurology. 150: 31-39. PMID 29496150 DOI: 10.1016/B978-0-444-63639-3.00003-7  1
2018 Chen J, Calhoun VD, Lin D, Perrone-Bizzozero NI, Bustillo JR, Pearlson GD, Potkin SG, van Erp TGM, Macciardi F, Ehrlich S, Ho BC, Sponheim SR, Wang L, Stephen JM, Mayer AR, ... ... Tamminga CA, et al. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. Schizophrenia Bulletin. PMID 29474680 DOI: 10.1093/Schbul/Sby010  0.76
2018 Gonzalez R, Suppes T, Zeitzer J, McClung C, Tamminga C, Tohen M, Forero A, Dwivedi A, Alvarado A. The association between mood state and chronobiological characteristics in bipolar I disorder: a naturalistic, variable cluster analysis-based study. International Journal of Bipolar Disorders. 6: 5. PMID 29457195 DOI: 10.1186/S40345-017-0113-5  1
2017 Tamminga CA, Pearlson GD, Stan AD, Gibbons RD, Padmanabhan J, Keshavan M, Clementz BA. Strategies for Advancing Disease Definition Using Biomarkers and Genetics: The Bipolar and Schizophrenia Network for Intermediate Phenotypes. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 20-27. PMID 29560884 DOI: 10.1016/J.Bpsc.2016.07.005  1
2017 Fontenot MR, Berto S, Liu Y, Werthmann G, Douglas C, Usui N, Gleason K, Tamminga CA, Takahashi JS, Konopka G. Novel transcriptional networks regulated by CLOCK in human neurons. Genes & Development. 31: 2121-2135. PMID 29196536 DOI: 10.1101/Gad.305813.117  1
2017 Freedman R, Lewis DA, Michels R, Pine DS, Rush AJ, Schultz SK, Tamminga CA, Katz R. 2017 in Review. The American Journal of Psychiatry. 174: 1140-1143. PMID 29191032 DOI: 10.1176/Appi.Ajp.2017.17101073  1
2017 Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, Janssen WG, Labonté B, Parise EM, Lorsch ZS, Golden SA, ... ... Tamminga C, et al. Social stress induces neurovascular pathology promoting depression. Nature Neuroscience. 20: 1752-1760. PMID 29184215 DOI: 10.1038/S41593-017-0010-3  1
2017 Jiang C, Lin WJ, Sadahiro M, Labonté B, Menard C, Pfau ML, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR. VGF function in depression and antidepressant efficacy. Molecular Psychiatry. PMID 29158577 DOI: 10.1038/Mp.2017.233  1
2017 Scott D, Tamminga CA. Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice. Behavioural Brain Research. PMID 29155005 DOI: 10.1016/J.Bbr.2017.10.039  1
2017 Lencer R, Mills LJ, Alliey-Rodriguez N, Shafee R, Lee AM, Reilly JL, Sprenger A, McDowell JE, McCarroll SA, Keshavan MS, Pearlson GD, Tamminga CA, Clementz BA, Gershon ES, Sweeney JA, et al. Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study. Translational Psychiatry. 7: e1249. PMID 29064472 DOI: 10.1038/Tp.2017.210  1
2017 Gershon ES, Pearlson G, Keshavan MS, Tamminga C, Clementz B, Buckley PF, Alliey-Rodriguez N, Liu C, Sweeney JA, Keedy S, Meda SA, Tandon N, Shafee R, Bishop JR, Ivleva EI. Genetic analysis of deep phenotyping projects in common disorders. Schizophrenia Research. PMID 29056493 DOI: 10.1016/J.Schres.2017.09.031  1
2017 Hudgens-Haney ME, Ethridge LE, McDowell JE, Keedy SK, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA. Psychosis subgroups differ in intrinsic neural activity but not task-specific processing. Schizophrenia Research. PMID 28844436 DOI: 10.1016/J.Schres.2017.08.023  1
2017 Labonté B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, Scarpa JR, Moy G, Loh YE, Cahill M, Lorsch ZS, Hamilton PJ, Calipari ES, Hodes GE, Issler O, ... ... Tamminga C, et al. Sex-specific transcriptional signatures in human depression. Nature Medicine. PMID 28825715 DOI: 10.1038/Nm.4386  1
2017 Hochberger WC, Combs T, Reilly JL, Bishop JR, Keefe RSE, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA, Hill SK, Sweeney JA. Deviation from expected cognitive ability across psychotic disorders. Schizophrenia Research. PMID 28545944 DOI: 10.1016/J.Schres.2017.05.019  1
2017 Sheffield JM, Kandala S, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA, Clementz BA, Lerman-Sinkoff DB, Hill SK, Barch DM. Transdiagnostic Associations Between Functional Brain Network Integrity and Cognition. Jama Psychiatry. PMID 28467520 DOI: 10.1001/Jamapsychiatry.2017.0669  1
2017 Hudgens-Haney ME, Ethridge LE, Knight JB, McDowell JE, Keedy SK, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA. Intrinsic neural activity differences among psychotic illnesses. Psychophysiology. PMID 28419491 DOI: 10.1111/Psyp.12875  1
2017 Eum S, Hill SK, Rubin LH, Carnahan RM, Reilly JL, Ivleva EI, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Gershon ES, Keshavan MS, Keefe RS, Sweeney JA, Bishop JR. Cognitive burden of anticholinergic medications in psychotic disorders. Schizophrenia Research. PMID 28390849 DOI: 10.1016/J.Schres.2017.03.034  1
2017 Tamminga CA. Developments in Somatic Treatment Introduction American Journal of Psychiatry. 151: 216-219. PMID 28296424 DOI: 10.1176/Appi.Ajp.151.6.216  0.01
2017 Du Y, Pearlson GD, Lin D, Sui J, Chen J, Salman M, Tamminga CA, Ivleva EI, Sweeney JA, Keshavan MS, Clementz BA, Bustillo J, Calhoun VD. Identifying dynamic functional connectivity biomarkers using GIG-ICA: Application to schizophrenia, schizoaffective disorder, and psychotic bipolar disorder. Human Brain Mapping. PMID 28294459 DOI: 10.1002/Hbm.23553  1
2017 Huang WC, Ferris E, Cheng T, Hörndli CS, Gleason K, Tamminga C, Wagner JD, Boucher KM, Christian JL, Gregg C. Diverse Non-genetic, Allele-Specific Expression Effects Shape Genetic Architecture at the Cellular Level in the Mammalian Brain. Neuron. PMID 28238550 DOI: 10.1016/J.Neuron.2017.01.033  1
2017 Rubin LH, Yao L, Keedy SK, Reilly JL, Bishop JR, Carter CS, Pournajafi-Nazarloo H, Drogos LL, Tamminga CA, Pearlson GD, Keshavan MS, Clementz BA, Hill SK, Liao W, Ji GJ, et al. Sex differences in associations of arginine vasopressin and oxytocin with resting-state functional brain connectivity. Journal of Neuroscience Research. 95: 576-586. PMID 27870395 DOI: 10.1002/Jnr.23820  1
2017 Eum S, Hill SK, Carnahan RM, Reilly JL, Ivleva EI, Rubin LH, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Gershon ES, Keefe RSE, Keshavan MS, Sweeney JA, Bishop JR. 68. Cognitive Burden of Anticholinergic Medications in Psychotic Disorders Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx021.107  1
2017 Lencer R, Mills LJ, Alliey-Rodriguez N, Reilly JL, Sprenger A, McDowell JE, Keshavan MS, Pearlson GD, McCarroll S, Tamminga CA, Clementz BA, Gershon ES, Sweeney JA, Bishop JR. Genome-Wide Association Studies Of Smooth Pursuit Eye Movements Across Psychotic Disorders: Preliminary Findings From The B-Snip Sample European Neuropsychopharmacology. 27. DOI: 10.1016/J.Euroneuro.2016.09.580  1
2017 Lutz O, Lizano P, Mothi SS, Tandon N, Tamminga C, Clementz B, Sweeney J, Pearlson G, Keshavan M. 965. Investigating Brain Structure Across Bipolar Disorder Subtypes: Findings from the Psychosis Affective Research Domain Intermediate Phenotypes (PARDIP) Study Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.691  1
2017 Ghose S, Mukherjee S, Pawar S, Durakoglugil D, Gleason K, Tamminga C, Hwang TH. 572. Cannabis Use and Matrix Metalloproteases in Schizophrenia Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.442  1
2016 Meda SA, Clementz BA, Sweeney JA, Keshavan MS, Tamminga CA, Ivleva EI, Pearlson GD. Examining Functional Resting-State Connectivity in Psychosis and Its Subgroups in the Bipolar-Schizophrenia Network on Intermediate Phenotypes Cohort. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 1: 488-497. PMID 29653095 DOI: 10.1016/J.Bpsc.2016.07.001  1
2016 Freedman R, Lewis DA, Michels R, Pine DS, Rush AJ, Schultz SK, Tamminga CA, Pier K. 2016 in Review. The American Journal of Psychiatry. 173: 1167-1170. PMID 27903107 DOI: 10.1176/Appi.Ajp.2016.16101120  1
2016 Braff DL, Tamminga CA. Endophenotypes, Epigenetics, Polygenicity and More: Irv Gottesman's Dynamic Legacy. Schizophrenia Bulletin. PMID 27872267 DOI: 10.1093/Schbul/Sbw157  0.01
2016 Ivleva EI, Clementz BA, Dutcher AM, Arnold SJ, Jeon-Slaughter H, Aslan S, Witte B, Poudyal G, Lu H, Meda SA, Pearlson GD, Sweeney JA, Keshavan MS, Tamminga CA. Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes. Biological Psychiatry. PMID 27817844 DOI: 10.1016/J.Biopsych.2016.08.030  1
2016 Hager B, Yang AC, Brady R, Meda S, Clementz B, Pearlson GD, Sweeney JA, Tamminga C, Keshavan M. Neural complexity as a potential translational biomarker for psychosis. Journal of Affective Disorders. PMID 27814962 DOI: 10.1016/J.Jad.2016.10.016  1
2016 Lepack AE, Bagot RC, Peña CJ, Loh YE, Farrelly LA, Lu Y, Powell SK, Lorsch ZS, Issler O, Cates HM, Tamminga CA, Molina H, Shen L, Nestler EJ, Allis CD, et al. Aberrant H3.3 dynamics in NAc promote vulnerability to depressive-like behavior. Proceedings of the National Academy of Sciences of the United States of America. PMID 27791098 DOI: 10.1073/Pnas.1608270113  1
2016 Tandon N, Nanda P, Padmanabhan JL, Mathew IT, Eack SM, Narayanan B, Meda SA, Bergen SE, Ruaño G, Windemuth A, Kocherla M, Petryshen TL, Clementz B, Sweeney J, Tamminga C, et al. Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses. Schizophrenia Research. PMID 27789186 DOI: 10.1016/J.Schres.2016.10.026  1
2016 Sweatt JD, Tamminga CA. An epigenomics approach to individual differences and its translation to neuropsychiatric conditions. Dialogues in Clinical Neuroscience. 18: 289-298. PMID 27757063  0.01
2016 Reilly JL, Hill SK, Gold JM, Keefe RS, Clementz BA, Gershon E, Keshavan MS, Pearlson G, Tamminga CA, Sweeney JA. Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. Schizophrenia Bulletin. PMID 27306316 DOI: 10.1093/Schbul/Sbw081  1
2016 Pearlson GD, Clementz BA, Sweeney JA, Keshavan MS, Tamminga CA. Does Biology Transcend the Symptom-based Boundaries of Psychosis? The Psychiatric Clinics of North America. 39: 165-74. PMID 27216897 DOI: 10.1016/J.Psc.2016.01.001  1
2016 Hanna RC, Shalvoy A, Cullum CM, Ivleva EI, Keshavan M, Pearlson G, Hill SK, Sweeney JA, Tamminga CA, Ghose S. Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use. Schizophrenia Bulletin. PMID 27033329 DOI: 10.1093/Schbul/Sbw030  1
2016 Shukla AA, Jha M, Birchfield T, Mukherjee S, Gleason K, Abdisalaam S, Asaithamby A, Adams-Huet B, Tamminga CA, Ghose S. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia. Schizophrenia Research. PMID 27021555 DOI: 10.1016/J.Schres.2016.03.019  1
2016 Padmanabhan JL, Nanda P, Tandon N, Mothi SS, Bolo N, McCarroll S, Clementz BA, Gershon ES, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives. Journal of Psychiatric Research. 77: 52-58. PMID 26978185 DOI: 10.1016/J.Jpsychires.2016.02.015  1
2016 Rubin LH, Connelly JJ, Reilly JL, Carter CS, Drogos LL, Pournajafi-Nazarloo H, Ruocco AC, Keedy SK, Matthew I, Tandon N, Pearlson GD, Clementz BA, Tamminga CA, Gershon ES, Keshavan MS, et al. Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders. Biological Psychiatry : Cognitive Neuroscience and Neuroimaging. 1: 141-151. PMID 26977453 DOI: 10.1016/J.Bpsc.2015.10.003  1
2016 Francis AN, Mothi SS, Mathew IT, Tandon N, Clementz B, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Callosal Abnormalities Across the Psychosis Dimension: Bipolar Schizophrenia Network on Intermediate Phenotypes. Biological Psychiatry. PMID 26954565 DOI: 10.1016/J.Biopsych.2015.12.026  1
2016 Puzziferri N, Zigman JM, Thomas BP, Mihalakos P, Gallagher R, Lutter M, Carmody T, Lu H, Tamminga CA. Brain imaging demonstrates a reduced neural impact of eating in obesity. Obesity (Silver Spring, Md.). PMID 26891710 DOI: 10.1002/Oby.21424  1
2015 Wang Z, Meda SA, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Schretlen DJ, Calhoun VD, Lui S, Pearlson GD. Large-Scale Fusion of Gray Matter and Resting-State Functional MRI Reveals Common and Distinct Biological Markers across the Psychosis Spectrum in the B-SNIP Cohort. Frontiers in Psychiatry. 6: 174. PMID 26732139 DOI: 10.3389/Fpsyt.2015.00174  1
2015 Nanda P, Tandon N, Mathew IT, Padmanabhan JL, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Impulsivity across the psychosis spectrum: Correlates of cortical volume, suicidal history, and social and global function. Schizophrenia Research. PMID 26711526 DOI: 10.1016/J.Schres.2015.11.030  1
2015 Clementz BA, Sweeney JA, Hamm JP, Ivleva EI, Ethridge LE, Pearlson GD, Keshavan MS, Tamminga CA. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. The American Journal of Psychiatry. appiajp201514091200. PMID 26651391 DOI: 10.1176/Appi.Ajp.2015.14091200  1
2015 Hochberger WC, Hill SK, Nelson CL, Reilly JL, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Sweeney JA. Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives. Schizophrenia Research. PMID 26645510 DOI: 10.1016/J.Schres.2015.11.022  1
2015 Freedman R, Lewis DA, Michels R, Pine DS, Rush AJ, Schultz SK, Tamminga CA, Radhakrishnan R. 2015 in Review. The American Journal of Psychiatry. 172: 1179-81. PMID 26619771 DOI: 10.1176/Appi.Ajp.2015.15091218  1
2015 Lencer R, Sprenger A, Reilly JL, McDowell JE, Rubin LH, Badner JA, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Clementz BA, Sweeney JA. Pursuit eye movements as an intermediate phenotype across psychotic disorders: Evidence from the B-SNIP study. Schizophrenia Research. PMID 26481615 DOI: 10.1016/J.Schres.2015.09.032  1
2015 Mokhtari M, Narayanan B, Hamm JP, Soh P, Calhoun VD, Ruaño G, Kocherla M, Windemuth A, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study. Schizophrenia Bulletin. PMID 26462502 DOI: 10.1093/Schbul/Sbv147  1
2015 Lieberman JA, Davis RE, Correll CU, Goff DC, Kane JM, Tamminga CA, Mates S, Vanover KE. ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial. Biological Psychiatry. PMID 26444072 DOI: 10.1016/J.Biopsych.2015.08.026  1
2015 Sun H, Damez-Werno DM, Scobie KN, Shao NY, Dias C, Rabkin J, Koo JW, Korb E, Bagot RC, Ahn FH, Cahill ME, Labonté B, Mouzon E, Heller EA, Cates H, ... ... Tamminga C, et al. ACF chromatin-remodeling complex mediates stress-induced depressive-like behavior. Nature Medicine. PMID 26390241 DOI: 10.1038/Nm.3939  1
2015 Tamminga CA, Zukin RS. Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology. Neuroscience. PMID 26211447 DOI: 10.1016/J.Neuroscience.2015.07.038  1
2015 Maze I, Wenderski W, Noh KM, Bagot RC, Tzavaras N, Purushothaman I, Elsässer SJ, Guo Y, Ionete C, Hurd YL, Tamminga CA, Halene T, Farrelly L, Soshnev AA, Wen D, et al. Critical Role of Histone Turnover in Neuronal Transcription and Plasticity. Neuron. 87: 77-94. PMID 26139371 DOI: 10.1016/J.Neuron.2015.06.014  1
2015 Samudra N, Ivleva EI, Hubbard NA, Rypma B, Sweeney JA, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA. Alterations in hippocampal connectivity across the psychosis dimension. Psychiatry Research. 233: 148-57. PMID 26123450 DOI: 10.1016/J.Pscychresns.2015.06.004  1
2015 Narayanan B, Soh P, Calhoun VD, Ruaño G, Kocherla M, Windemuth A, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Multivariate genetic determinants of EEG oscillations in schizophrenia and psychotic bipolar disorder from the BSNIP study. Translational Psychiatry. 5: e588. PMID 26101851 DOI: 10.1038/Tp.2015.76  1
2015 Meda SA, Wang Z, Ivleva EI, Poudyal G, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Schretlen DJ, Calhoun VD, Lui S, Damaraju E, Pearlson GD. Frequency-Specific Neural Signatures of Spontaneous Low-Frequency Resting State Fluctuations in Psychosis: Evidence From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Consortium. Schizophrenia Bulletin. 41: 1336-48. PMID 26012519 DOI: 10.1093/Schbul/Sbv064  1
2015 Kristian Hill S, Buchholz A, Amsbaugh H, Reilly JL, Rubin LH, Gold JM, Keefe RS, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. Schizophrenia Research. 166: 310-5. PMID 26008884 DOI: 10.1016/J.Schres.2015.05.018  1
2015 Mothi SS, Tandon N, Padmanabhan J, Mathew IT, Clementz B, Tamminga C, Pearlson G, Sweeney J, Keshavan MS. Increased cardiometabolic dysfunction in first-degree relatives of patients with psychotic disorders. Schizophrenia Research. 165: 103-7. PMID 25900543 DOI: 10.1016/J.Schres.2015.03.034  1
2015 Pinkham AE, Liu P, Lu H, Kriegsman M, Simpson C, Tamminga C. Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia. The American Journal of Psychiatry. appiajp201414081000. PMID 25815418 DOI: 10.1176/Appi.Ajp.2014.14081000  1
2015 Narayanan B, Ethridge LE, O'Neil K, Dunn S, Mathew I, Tandon N, Calhoun VD, Ruaño G, Kocherla M, Windemuth A, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Genetic Sources of Subcomponents of Event-Related Potential in the Dimension of Psychosis Analyzed From the B-SNIP Study. The American Journal of Psychiatry. 172: 466-78. PMID 25615564 DOI: 10.1176/Appi.Ajp.2014.13101411  1
2015 Li W, Ghose S, Gleason K, Begovic A, Perez J, Bartko J, Russo S, Wagner AD, Selemon L, Tamminga CA. Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. The American Journal of Psychiatry. 172: 373-82. PMID 25585032 DOI: 10.1176/Appi.Ajp.2014.14010123  1
2015 Giakoumatos CI, Nanda P, Mathew IT, Tandon N, Shah J, Bishop JR, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder. Journal of Psychiatric Research. 61: 180-7. PMID 25563516 DOI: 10.1016/J.Jpsychires.2014.12.008  1
2015 Clementz BA, Sweeney J, Keshavan MS, Pearlson G, Tamminga CA. Using biomarker batteries. Biological Psychiatry. 77: 90-2. PMID 25524306 DOI: 10.1016/J.Biopsych.2014.10.012  1
2015 Brown ES, Jeon-Slaughter H, Lu H, Jamadar R, Issac S, Shad M, Denniston D, Tamminga C, Nakamura A, Thomas BP. Hippocampal volume in healthy controls given 3-day stress doses of hydrocortisone. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1216-21. PMID 25409592 DOI: 10.1038/Npp.2014.307  1
2015 Hill SK, Reilly JL, Ragozzino ME, Rubin LH, Bishop JR, Gur RC, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Keefe RS, Sweeney JA. Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. Schizophrenia Bulletin. 41: 940-50. PMID 25194139 DOI: 10.1093/Schbul/Sbu130  1
2015 Lui S, Yao L, Xiao Y, Keedy SK, Reilly JL, Keefe RS, Tamminga CA, Keshavan MS, Pearlson GD, Gong Q, Sweeney JA. Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives. Psychological Medicine. 45: 97-108. PMID 25066779 DOI: 10.1017/S003329171400110X  1
2015 Ethridge LE, Hamm JP, Pearlson GD, Tamminga CA, Sweeney JA, Keshavan MS, Clementz BA. Event-related potential and time-frequency endophenotypes for schizophrenia and psychotic bipolar disorder. Biological Psychiatry. 77: 127-36. PMID 24923619 DOI: 10.1016/J.Biopsych.2014.03.032  1
2015 Stan AD, Ghose S, Zhao C, Hulsey K, Mihalakos P, Yanagi M, Morris SU, Bartko JJ, Choi C, Tamminga CA. Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia. Molecular Psychiatry. 20: 433-9. PMID 24912493 DOI: 10.1038/Mp.2014.54  1
2015 Padmanabhan JL, Tandon N, Haller CS, Mathew IT, Eack SM, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Correlations between brain structure and symptom dimensions of psychosis in schizophrenia, schizoaffective, and psychotic bipolar I disorders. Schizophrenia Bulletin. 41: 154-62. PMID 24907239 DOI: 10.1093/Schbul/Sbu075  1
2015 Arnold SJ, Ivleva EI, Gopal TA, Reddy AP, Jeon-Slaughter H, Sacco CB, Francis AN, Tandon N, Bidesi AS, Witte B, Poudyal G, Pearlson GD, Sweeney JA, Clementz BA, Keshavan MS, ... Tamminga CA, et al. Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer). Schizophrenia Bulletin. 41: 233-49. PMID 24557771 DOI: 10.1093/Schbul/Sbu009  1
2015 Samudra N, Ivleva EI, Hubbard NA, Rypma B, Sweeney JA, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA. Alterations in hippocampal connectivity across the psychosis dimension Psychiatry Research - Neuroimaging. 233: 148-157. DOI: 10.1016/j.pscychresns.2015.06.004  1
2014 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Richards M. 2014 in review. The American Journal of Psychiatry. 171: 1243-7. PMID 25756764 DOI: 10.1176/Appi.Ajp.2014.14091156  1
2014 Bharadwaj R, Peter CJ, Jiang Y, Roussos P, Vogel-Ciernia A, Shen EY, Mitchell AC, Mao W, Whittle C, Dincer A, Jakovcevski M, Pothula V, Rasmussen TP, Giakoumaki SG, Bitsios P, ... ... Tamminga C, et al. Conserved higher-order chromatin regulates NMDA receptor gene expression and cognition. Neuron. 84: 997-1008. PMID 25467983 DOI: 10.1016/J.Neuron.2014.10.032  1
2014 Dias C, Feng J, Sun H, Shao NY, Mazei-Robison MS, Damez-Werno D, Scobie K, Bagot R, LaBonté B, Ribeiro E, Liu X, Kennedy P, Vialou V, Ferguson D, Peña C, ... ... Tamminga C, et al. β-catenin mediates stress resilience through Dicer1/microRNA regulation. Nature. 516: 51-5. PMID 25383518 DOI: 10.1038/Nature13976  1
2014 Ethridge LE, Soilleux M, Nakonezny PA, Reilly JL, Hill SK, Keefe RS, Gershon ES, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA. Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. Schizophrenia Research. 159: 491-8. PMID 25261042 DOI: 10.1016/J.Schres.2014.08.025  1
2014 Krawczyk DC, Kandalaft MR, Didehbani N, Allen TT, McClelland MM, Tamminga CA, Chapman SB. An investigation of reasoning by analogy in schizophrenia and autism spectrum disorder. Frontiers in Human Neuroscience. 8: 517. PMID 25191240 DOI: 10.3389/Fnhum.2014.00517  1
2014 Das T, Ivleva EI, Wagner AD, Stark CE, Tamminga CA. Loss of pattern separation performance in schizophrenia suggests dentate gyrus dysfunction. Schizophrenia Research. 159: 193-7. PMID 25176349 DOI: 10.1016/J.Schres.2014.05.006  1
2014 Ruocco AC, Reilly JL, Rubin LH, Daros AR, Gershon ES, Tamminga CA, Pearlson GD, Hill SK, Keshavan MS, Gur RC, Sweeney JA. Emotion recognition deficits in schizophrenia-spectrum disorders and psychotic bipolar disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Schizophrenia Research. 158: 105-12. PMID 25052782 DOI: 10.1016/J.Schres.2014.07.001  1
2014 Mathew I, Gardin TM, Tandon N, Eack S, Francis AN, Seidman LJ, Clementz B, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Jama Psychiatry. 71: 769-77. PMID 24828364 DOI: 10.1001/Jamapsychiatry.2014.453  1
2014 Meda SA, Ruaño G, Windemuth A, O'Neil K, Berwise C, Dunn SM, Boccaccio LE, Narayanan B, Kocherla M, Sprooten E, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Calhoun VD, et al. Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 111: E2066-75. PMID 24778245 DOI: 10.1073/Pnas.1313093111  1
2014 Liu P, Lu H, Filbey FM, Tamminga CA, Cao Y, Adinoff B. MRI assessment of cerebral oxygen metabolism in cocaine-addicted individuals: hypoactivity and dose dependence. Nmr in Biomedicine. 27: 726-32. PMID 24757009 DOI: 10.1002/Nbm.3114  1
2014 Hamm JP, Ethridge LE, Boutros NN, Keshavan MS, Sweeney JA, Pearlson GD, Tamminga CA, Clementz BA. Diagnostic specificity and familiality of early versus late evoked potentials to auditory paired stimuli across the schizophrenia-bipolar psychosis spectrum. Psychophysiology. 51: 348-57. PMID 24660885 DOI: 10.1111/Psyp.12185  1
2014 Rubin LH, Carter CS, Bishop JR, Pournajafi-Nazarloo H, Drogos LL, Hill SK, Ruocco AC, Keedy SK, Reilly JL, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Sweeney JA. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophrenia Bulletin. 40: 1374-84. PMID 24619535 DOI: 10.1093/Schbul/Sbu027  1
2014 Tamminga CA, Pearlson G, Keshavan M, Sweeney J, Clementz B, Thaker G. Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum. Schizophrenia Bulletin. 40: S131-7. PMID 24562492 DOI: 10.1093/Schbul/Sbt179  1
2014 Gonzalez R, Tamminga CA, Tohen M, Suppes T. The relationship between affective state and the rhythmicity of activity in bipolar disorder. The Journal of Clinical Psychiatry. 75: e317-22. PMID 24500063 DOI: 10.4088/Jcp.13M08506  1
2014 Tamminga CA. Approaching human neuroscience for disease understanding. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 13: 41-3. PMID 24497244 DOI: 10.1002/Wps.20099  0.01
2014 Narayanan B, O'Neil K, Berwise C, Stevens MC, Calhoun VD, Clementz BA, Tamminga CA, Sweeney JA, Keshavan MS, Pearlson GD. Resting state electroencephalogram oscillatory abnormalities in schizophrenia and psychotic bipolar patients and their relatives from the bipolar and schizophrenia network on intermediate phenotypes study. Biological Psychiatry. 76: 456-65. PMID 24439302 DOI: 10.1016/J.Biopsych.2013.12.008  1
2014 Nanda P, Tandon N, Mathew IT, Giakoumatos CI, Abhishekh HA, Clementz BA, Pearlson GD, Sweeney J, Tamminga CA, Keshavan MS. Local gyrification index in probands with psychotic disorders and their first-degree relatives. Biological Psychiatry. 76: 447-55. PMID 24369266 DOI: 10.1016/J.Biopsych.2013.11.018  1
2014 Robison AJ, Vialou V, Sun HS, Labonte B, Golden SA, Dias C, Turecki G, Tamminga C, Russo S, Mazei-Robison M, Nestler EJ. Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1178-86. PMID 24240473 DOI: 10.1038/Npp.2013.319  1
2014 Reilly JL, Frankovich K, Hill S, Gershon ES, Keefe RS, Keshavan MS, Pearlson GD, Tamminga CA, Sweeney JA. Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. Schizophrenia Bulletin. 40: 1011-21. PMID 24080895 DOI: 10.1093/Schbul/Sbt132  1
2014 Dietz DM, Kennedy PJ, Sun H, Maze I, Gancarz AM, Vialou V, Koo JW, Mouzon E, Ghose S, Tamminga CA, Nestler EJ. ΔFosB induction in prefrontal cortex by antipsychotic drugs is associated with negative behavioral outcomes. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 538-44. PMID 24067299 DOI: 10.1038/Npp.2013.255  1
2014 Rosenfeld ES, Pearlson GD, Sweeney JA, Tamminga CA, Keshavan MS, Nonterah C, Stevens MC. Prolonged hemodynamic response during incidental facial emotion processing in inter-episode bipolar I disorder. Brain Imaging and Behavior. 8: 73-86. PMID 23975275 DOI: 10.1007/S11682-013-9246-Z  1
2014 Unschuld PG, Buchholz AS, Varvaris M, van Zijl PC, Ross CA, Pekar JJ, Hock C, Sweeney JA, Tamminga CA, Keshavan MS, Pearlson GD, Thaker GK, Schretlen DJ. Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction. Schizophrenia Bulletin. 40: 653-64. PMID 23778975 DOI: 10.1093/schbul/sbt077  1
2014 Yanagi M, Joho RH, Southcott SA, Shukla AA, Ghose S, Tamminga CA. Kv3.1-containing K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs. Molecular Psychiatry. 19: 573-9. PMID 23628987 DOI: 10.1038/Mp.2013.49  1
2014 Ivleva EI, Moates AF, Hamm JP, Bernstein IH, O'Neill HB, Cole D, Clementz BA, Thaker GK, Tamminga CA. Smooth pursuit eye movement, prepulse inhibition, and auditory paired stimuli processing endophenotypes across the schizophrenia-bipolar disorder psychosis dimension. Schizophrenia Bulletin. 40: 642-52. PMID 23599252 DOI: 10.1093/Schbul/Sbt047  1
2014 Arey RN, Enwright JF, Spencer SM, Falcon E, Ozburn AR, Ghose S, Tamminga C, McClung CA. An important role for cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors. Molecular Psychiatry. 19: 342-50. PMID 23399917 DOI: 10.1038/Mp.2013.12  1
2014 Arey RN, Enwright JF, Spencer SM, Falcon E, Ozburn AR, Ghose S, Tamminga C, Mcclung CA. Erratum: An important role for Cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors (Molecular Psychiatry (2013) DOI:10.1038/mp.2013.12) Molecular Psychiatry. 19. DOI: 10.1038/Mp.2013.47  1
2014 Padmanabhan J, Tandon N, Haller C, Mathew I, Ruano G, Windemuth A, Clementz B, Sweeney J, Pearlson GD, Tamminga C, Keshavan M. Poster #S141 ASSOCIATIONS BETWEEN POLYGENIC RISK SCORES FOR TYPE 2 DIABETES MELLITUS AND CO-MORBID DIABETES IN A SAMPLE OF SUBJECTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE, OR BIPOLAR I DISORDERS Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70420-7  1
2013 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Vahabzadeh A. 2013 in review. The American Journal of Psychiatry. 170: 1388-92. PMID 24306335 DOI: 10.1176/Appi.Ajp.2013.13091260  1
2013 Ivleva EI, Bidesi AS, Keshavan MS, Pearlson GD, Meda SA, Dodig D, Moates AF, Lu H, Francis AN, Tandon N, Schretlen DJ, Sweeney JA, Clementz BA, Tamminga CA. Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). The American Journal of Psychiatry. 170: 1285-96. PMID 24185241 DOI: 10.1176/Appi.Ajp.2013.13010126  1
2013 Hamm JP, Ethridge LE, Shapiro JR, Pearlson GD, Tamminga CA, Sweeney JA, Keshavan MS, Thaker GK, Clementz BA. Family history of psychosis moderates early auditory cortical response abnormalities in non-psychotic bipolar disorder. Bipolar Disorders. 15: 774-86. PMID 23941660 DOI: 10.1111/Bdi.12110  1
2013 Giakoumatos CI, Tandon N, Shah J, Mathew IT, Brady RO, Clementz BA, Pearlson GD, Thaker GK, Tamminga CA, Sweeney JA, Keshavan MS. Are structural brain abnormalities associated with suicidal behavior in patients with psychotic disorders? Journal of Psychiatric Research. 47: 1389-95. PMID 23866739 DOI: 10.1016/J.Jpsychires.2013.06.011  1
2013 Tamminga CA, Ivleva EI, Keshavan MS, Pearlson GD, Clementz BA, Witte B, Morris DW, Bishop J, Thaker GK, Sweeney JA. Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). The American Journal of Psychiatry. 170: 1263-74. PMID 23846857 DOI: 10.1176/Appi.Ajp.2013.12101339  1
2013 Skudlarski P, Schretlen DJ, Thaker GK, Stevens MC, Keshavan MS, Sweeney JA, Tamminga CA, Clementz BA, O'Neil K, Pearlson GD. Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. The American Journal of Psychiatry. 170: 886-98. PMID 23771210 DOI: 10.1176/Appi.Ajp.2013.12111448  1
2013 Hill SK, Reilly JL, Keefe RS, Gold JM, Bishop JR, Gershon ES, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA. Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. The American Journal of Psychiatry. 170: 1275-84. PMID 23771174 DOI: 10.1176/Appi.Ajp.2013.12101298  1
2013 Khadka S, Meda SA, Stevens MC, Glahn DC, Calhoun VD, Sweeney JA, Tamminga CA, Keshavan MS, O'Neil K, Schretlen D, Pearlson GD. Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biological Psychiatry. 74: 458-66. PMID 23746539 DOI: 10.1016/J.Biopsych.2013.04.024  1
2013 Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, Russo SJ, Vialou V, Caldarone BJ, Tamminga CA, Nestler EJ, Zachariou V. Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proceedings of the National Academy of Sciences of the United States of America. 110: 8254-9. PMID 23630294 DOI: 10.1073/Pnas.1214696110  1
2013 Keshavan MS, Clementz BA, Pearlson GD, Sweeney JA, Tamminga CA. Reimagining psychoses: an agnostic approach to diagnosis. Schizophrenia Research. 146: 10-6. PMID 23498153 DOI: 10.1016/J.Schres.2013.02.022  1
2013 Gonzalez R, Tamminga C, Tohen M, Suppes T. Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder. Journal of Affective Disorders. 149: 363-6. PMID 23489400 DOI: 10.1016/J.Jad.2013.02.013  1
2013 Brown ES, Lu H, Denniston D, Uh J, Thomas BP, Carmody TJ, Auchus RJ, Diaz-Arrastia R, Tamminga C. A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes. Journal of Affective Disorders. 150: 551-8. PMID 23453674 DOI: 10.1016/J.Jad.2013.01.038  1
2013 Golden SA, Christoffel DJ, Heshmati M, Hodes GE, Magida J, Davis K, Cahill ME, Dias C, Ribeiro E, Ables JL, Kennedy PJ, Robison AJ, Gonzalez-Maeso J, Neve RL, Turecki G, ... ... Tamminga CA, et al. Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nature Medicine. 19: 337-44. PMID 23416703 DOI: 10.1038/Nm.3090  1
2013 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Gabbard GO, Gau SS, Javitt DC, Oquendo MA, Shrout PE, Vieta E, Yager J. The initial field trials of DSM-5: new blooms and old thorns. The American Journal of Psychiatry. 170: 1-5. PMID 23288382 DOI: 10.1176/Appi.Ajp.2012.12091189  1
2013 Tamminga CA. Psychosis is emerging as a learning and memory disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 247. PMID 23147488 DOI: 10.1038/Npp.2012.187  0.01
2013 Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, Russo SJ, Vialou V, Caldarone BJ, Tamminga CA, Nestler EJ, Zachariou V. Regulator of G protein signaling is a crucial modulator of antidepressant drug action in depression and neuropathic pain models(Proceedings of the National Academy of Sciences of the United States of America (2013) 110, 20 (8254-8259)) Proceedings of the National Academy of Sciences of the United States of America. 110: 11660. DOI: 10.1073/Pnas.1311399110  1
2012 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Seawell M. 2012 in review. The American Journal of Psychiatry. 169: 1233-7. PMID 23212053 DOI: 10.1176/Appi.Ajp.2012.12091250  1
2012 Ivleva EI, Bidesi AS, Thomas BP, Meda SA, Francis A, Moates AF, Witte B, Keshavan MS, Tamminga CA. Brain gray matter phenotypes across the psychosis dimension. Psychiatry Research. 204: 13-24. PMID 23177922 DOI: 10.1016/J.Pscychresns.2012.05.001  1
2012 Didehbani N, Shad MU, Tamminga CA, Kandalaft MR, Allen TT, Chapman SB, Krawczyk DC. Insight and empathy in schizophrenia. Schizophrenia Research. 142: 246-7. PMID 23043874 DOI: 10.1016/J.Schres.2012.09.010  1
2012 Saricicek A, Esterlis I, Maloney KH, Mineur YS, Ruf BM, Muralidharan A, Chen JI, Cosgrove KP, Kerestes R, Ghose S, Tamminga CA, Pittman B, Bois F, Tamagnan G, Seibyl J, et al. Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. The American Journal of Psychiatry. 169: 851-9. PMID 22772158 DOI: 10.1176/Appi.Ajp.2012.11101546  1
2012 Banerjee A, Ganji S, Hulsey K, Dimitrov I, Maher E, Ghose S, Tamminga C, Choi C. Measurement of glycine in gray and white matter in the human brain in vivo by 1H MRS at 7.0 T. Magnetic Resonance in Medicine. 68: 325-31. PMID 22693073 DOI: 10.1002/Mrm.24368  1
2012 Ethridge LE, Hamm JP, Shapiro JR, Summerfelt AT, Keedy SK, Stevens MC, Pearlson G, Tamminga CA, Boutros NN, Sweeney JA, Keshavan MS, Thaker G, Clementz BA. Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. Biological Psychiatry. 72: 766-74. PMID 22572033 DOI: 10.1016/J.Biopsych.2012.03.034  1
2012 Moates AF, Ivleva EI, O'Neill HB, Krishna N, Cullum CM, Thaker GK, Tamminga CA. Predictive pursuit association with deficits in working memory in psychosis. Biological Psychiatry. 72: 752-7. PMID 22554452 DOI: 10.1016/J.Biopsych.2012.03.030  1
2012 Ivleva EI, Shohamy D, Mihalakos P, Morris DW, Carmody T, Tamminga CA. Memory generalization is selectively altered in the psychosis dimension. Schizophrenia Research. 138: 74-80. PMID 22551681 DOI: 10.1016/J.Schres.2012.04.004  1
2012 Tamminga CA, Southcott S, Sacco C, Wagner AD, Ghose S. Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling. Schizophrenia Bulletin. 38: 927-35. PMID 22532703 DOI: 10.1093/Schbul/Sbs062  1
2012 Didehbani N, Shad MU, Kandalaft MR, Allen TT, Tamminga CA, Krawczyk DC, Chapman SB. Brief report: Insight into illness and social attributional style in Asperger's syndrome. Journal of Autism and Developmental Disorders. 42: 2754-60. PMID 22527705 DOI: 10.1007/S10803-012-1532-X  1
2012 Shad MU, Keshavan MS, Steinberg JL, Mihalakos P, Thomas BP, Motes MA, Soares JC, Tamminga CA. Neurobiology of self-awareness in schizophrenia: an fMRI study. Schizophrenia Research. 138: 113-9. PMID 22480958 DOI: 10.1016/J.Schres.2012.03.016  1
2012 Tamminga CA, Thomas BP, Chin R, Mihalakos P, Youens K, Wagner AD, Preston AR. Hippocampal novelty activations in schizophrenia: disease and medication effects. Schizophrenia Research. 138: 157-63. PMID 22480957 DOI: 10.1016/J.Schres.2012.03.019  1
2012 Meda SA, Gill A, Stevens MC, Lorenzoni RP, Glahn DC, Calhoun VD, Sweeney JA, Tamminga CA, Keshavan MS, Thaker G, Pearlson GD. Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biological Psychiatry. 71: 881-9. PMID 22401986 DOI: 10.1016/J.Biopsych.2012.01.025  1
2012 Ivleva EI, Morris DW, Osuji J, Moates AF, Carmody TJ, Thaker GK, Cullum M, Tamminga CA. Cognitive endophenotypes of psychosis within dimension and diagnosis. Psychiatry Research. 196: 38-44. PMID 22342122 DOI: 10.1016/J.Psychres.2011.08.021  1
2012 Ibrahim HM, Tamminga CA. Treating Impaired Cognition in Schizophrenia Current Pharmaceutical Biotechnology. 13: 1587-1594. PMID 22283754 DOI: 10.2174/138920112800784772  1
2012 Tao R, Calley CS, Hart J, Mayes TL, Nakonezny PA, Lu H, Kennard BD, Tamminga CA, Emslie GJ. Brain activity in adolescent major depressive disorder before and after fluoxetine treatment. The American Journal of Psychiatry. 169: 381-8. PMID 22267183 DOI: 10.1176/Appi.Ajp.2011.11040615  1
2012 Hamm JP, Ethridge LE, Shapiro JR, Stevens MC, Boutros NN, Summerfelt AT, Keshavan MS, Sweeney JA, Pearlson G, Tamminga CA, Thaker G, Clementz BA. Spatiotemporal and frequency domain analysis of auditory paired stimuli processing in schizophrenia and bipolar disorder with psychosis. Psychophysiology. 49: 522-30. PMID 22176721 DOI: 10.1111/J.1469-8986.2011.01327.X  1
2012 Yanagi M, Southcott S, Lister J, Tamminga CA. Animal models of schizophrenia emphasizing construct validity. Progress in Molecular Biology and Translational Science. 105: 411-44. PMID 22137438 DOI: 10.1016/B978-0-12-394596-9.00012-3  1
2012 Bobb DS, Adinoff B, Laken SJ, McClintock SM, Rubia K, Huang HW, Husain MM, Mapes KS, Tamminga C, Cullum CM, Gopinath K, Trivedi MH, Kozel FA. Neural correlates of successful response inhibition in unmedicated patients with late-life depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 1057-69. PMID 21997605 DOI: 10.1097/Jgp.0B013E318235B728  1
2012 Ethridge LE, Hamm JP, Shapiro JR, Summerfelt AT, Keedy SK, Stevens MC, Pearlson G, Tamminga CA, Boutros NN, Sweeney JA, Keshavan MS, Thaker G, Clementz BA. Late beta accentuation and decreased N2 amplitude to auditory oddball stimuli discriminate psychosis groups and co-occur in first-degree relatives F1000research. 3. DOI: 10.7490/F1000Research.1090558.1  1
2012 Hamm JP, Ethridge LE, Shapiro JR, Parker EM, Keshavan MS, Sweeney JA, Pearlson G, Tamminga CA, Thaker G, Clementz BA. Auditory evoked oscillations discriminate major mood and psychotic diagnoses F1000research. 3. DOI: 10.7490/F1000Research.1090223.1  1
2012 Kandalaft MR, Didehbani N, Cullum CM, Krawczyk DC, Allen TT, Tamminga CA, Chapman SB. The Wechsler ACS Social Perception Subtest: A Preliminary Comparison With Other Measures of Social Cognition Journal of Psychoeducational Assessment. 30: 455-465. DOI: 10.1177/0734282912436411  1
2012 Tamminga C. The Role of the Hippocampal Subfield System in Schizophrenia Psychosis Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70202-5  0.01
2011 Keshavan MS, Morris DW, Sweeney JA, Pearlson G, Thaker G, Seidman LJ, Eack SM, Tamminga C. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophrenia Research. 133: 250-4. PMID 21996268 DOI: 10.1016/J.Schres.2011.09.005  1
2011 Covington HE, Maze I, Sun H, Bomze HM, DeMaio KD, Wu EY, Dietz DM, Lobo MK, Ghose S, Mouzon E, Neve RL, Tamminga CA, Nestler EJ. A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron. 71: 656-70. PMID 21867882 DOI: 10.1016/J.Neuron.2011.06.007  1
2011 Tamminga CA. When is polypharmacy an advantage? The American Journal of Psychiatry. 168: 663. PMID 21724668 DOI: 10.1176/Appi.Ajp.2011.11050695  0.01
2011 Wilkinson MB, Dias C, Magida J, Mazei-Robison M, Lobo M, Kennedy P, Dietz D, Covington H, Russo S, Neve R, Ghose S, Tamminga C, Nestler EJ. A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 9084-92. PMID 21697359 DOI: 10.1523/Jneurosci.0039-11.2011  1
2011 Kozel FA, Rao U, Lu H, Nakonezny PA, Grannemann B, McGregor T, Croarkin PE, Mapes KS, Tamminga CA, Trivedi MH. Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder. Frontiers in Psychiatry. 2: 7. PMID 21556277 DOI: 10.3389/Fpsyt.2011.00007  1
2011 Huang H, Prince JL, Mishra V, Carass A, Landman B, Park DC, Tamminga C, King R, Miller MI, van Zijl PC, Mori S. A framework on surface-based connectivity quantification for the human brain. Journal of Neuroscience Methods. 197: 324-32. PMID 21396960 DOI: 10.1016/J.Jneumeth.2011.02.017  1
2011 Ibrahim HM, Tamminga CA. Schizophrenia: Treatment targets beyond monoamine systems Annual Review of Pharmacology and Toxicology. 51: 189-209. PMID 20868275 DOI: 10.1146/Annurev.Pharmtox.010909.105851  1
2011 Ghose S, Winter MK, McCarson KE, Tamminga CA, Enna SJ. The GABAβ receptor as a target for antidepressant drug action. British Journal of Pharmacology. 162: 1-17. PMID 20735410 DOI: 10.1111/J.1476-5381.2010.01004.X  1
2011 Chandrasekaran A, Mears R, Ramaswamy S, Tandon N, Mudan A, Mitra P, Hajj MA, Hamil A, Nordin M, Wojcik J, McInnis M, Boutros N, Pearlson G, Sweeney J, Tamminga C, et al. Preliminary studies of altered synchronous gamma oscillatory activity in schizophrenia, bipolar disorder, and genetically high risk individuals under steady state response F1000research. 2. DOI: 10.7490/F1000Research.1658.1  1
2011 Skudlarski P, Schretlen D, Thaker G, Stevens M, Keshavan, Sweeney J, Tamminga C, Gill A, Fieldstone S, Pearlson G. White matter abnormalities in persons with schizophrenia and psychotic bipolar disorder and their relatives F1000research. 2. DOI: 10.7490/F1000Research.1419.1  1
2010 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA. 2010 in Review. The American Journal of Psychiatry. 167: 1431-1434. PMID 26650134 DOI: 10.1176/Appi.Ajp.2010.10091371  1
2010 Covington HE, Lobo MK, Maze I, Vialou V, Hyman JM, Zaman S, LaPlant Q, Mouzon E, Ghose S, Tamminga CA, Neve RL, Deisseroth K, Nestler EJ. Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 16082-90. PMID 21123555 DOI: 10.1523/Jneurosci.1731-10.2010  1
2010 Vialou V, Maze I, Renthal W, LaPlant QC, Watts EL, Mouzon E, Ghose S, Tamminga CA, Nestler EJ. Serum response factor promotes resilience to chronic social stress through the induction of DeltaFosB. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 14585-92. PMID 20980616 DOI: 10.1523/Jneurosci.2496-10.2010  1
2010 Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Arango-Llievano M, Ghose S, Vernov M, Stavarache M, Stavarche M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Science Translational Medicine. 2: 54ra76. PMID 20962330 DOI: 10.1126/Scitranslmed.3001079  1
2010 Tamminga CA, Stan AD, Wagner AD. The hippocampal formation in schizophrenia. The American Journal of Psychiatry. 167: 1178-93. PMID 20810471 DOI: 10.1176/Appi.Ajp.2010.09081187  1
2010 Vialou V, Robison AJ, Laplant QC, Covington HE, Dietz DM, Ohnishi YN, Mouzon E, Rush AJ, Watts EL, Wallace DL, Iñiguez SD, Ohnishi YH, Steiner MA, Warren BL, Krishnan V, ... ... Tamminga CA, et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nature Neuroscience. 13: 745-52. PMID 20473292 DOI: 10.1038/Nn.2551  1
2010 Rowland LM, Beason-Held L, Tamminga CA, Holcomb HH. The interactive effects of ketamine and nicotine on human cerebral blood flow. Psychopharmacology. 208: 575-84. PMID 20066400 DOI: 10.1007/S00213-009-1758-2  1
2010 Shohamy D, Mihalakos P, Chin R, Thomas B, Wagner AD, Tamminga C. Learning and generalization in schizophrenia: effects of disease and antipsychotic drug treatment. Biological Psychiatry. 67: 926-32. PMID 20034612 DOI: 10.1016/J.Biopsych.2009.10.025  1
2010 Ivleva EI, Morris DW, Moates AF, Suppes T, Thaker GK, Tamminga CA. Genetics and intermediate phenotypes of the schizophrenia--bipolar disorder boundary. Neuroscience and Biobehavioral Reviews. 34: 897-921. PMID 19954751 DOI: 10.1016/J.Neubiorev.2009.11.022  1
2010 Castillo MA, Ghose S, Tamminga CA, Ulery-Reynolds PG. Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex. Biological Psychiatry. 67: 208-16. PMID 19748077 DOI: 10.1016/J.Biopsych.2009.07.029  1
2010 Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S, Vernov M, Stavarache M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens (Science Translational Medicine (2010) 2, (62er4)) Science Translational Medicine. 2. DOI: 10.1126/Scitranslmed.3001996  1
2010 Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Llievano M, Ghose S, Vernov M, Stavarche M, Musatov S, Flajolet M, Svenningsson P, Greengard P, Kaplitt MG. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens (Science Translational Medicine (2010) 2, (55er3)) Science Translational Medicine. 2. DOI: 10.1126/scitranslmed.3001841  1
2009 Tamminga CA, Michels R, Pine DS, Schultz SK, Lewis DA, Freedman R. 2009 in review. The American Journal of Psychiatry. 166: 1318-21. PMID 19952081 DOI: 10.1176/Appi.Ajp.2009.09101458  1
2009 Hesdorffer DC, Rauch SL, Tamminga CA. Long-term psychiatric outcomes following traumatic brain injury: a review of the literature. The Journal of Head Trauma Rehabilitation. 24: 452-9. PMID 19940678 DOI: 10.1097/Htr.0B013E3181C133Fd  0.01
2009 Covington HE, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, et al. Antidepressant actions of histone deacetylase inhibitors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 11451-60. PMID 19759294 DOI: 10.1523/Jneurosci.1758-09.2009  1
2009 Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Cropsey KL. Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2675-90. PMID 19675535 DOI: 10.1038/Npp.2009.94  1
2009 Choi C, Dimitrov I, Douglas D, Zhao C, Hawesa H, Ghose S, Tamminga CA. In vivo detection of serine in the human brain by proton magnetic resonance spectroscopy (1H-MRS) at 7 Tesla. Magnetic Resonance in Medicine. 62: 1042-6. PMID 19526507 DOI: 10.1002/Mrm.22079  1
2009 Ghose S, Gleason KA, Potts BW, Lewis-Amezcua K, Tamminga CA. Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action? The American Journal of Psychiatry. 166: 812-20. PMID 19487395 DOI: 10.1176/Appi.Ajp.2009.08091445  1
2009 Ghose S, Chin R, Gallegos A, Roberts R, Coyle J, Tamminga C. Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia Schizophrenia Research. 111: 131-137. PMID 19403271 DOI: 10.1016/J.Schres.2009.03.038  1
2009 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Andreasen NC, Brady KT, Brent DA, Brzustowicz L, Carter CS, Eisenberg L, Goldman H, Javitt DC, Leibenluft E, et al. Conflict of interest-- an issue for every psychiatrist. The American Journal of Psychiatry. 166: 274. PMID 19255048 DOI: 10.1176/Appi.Ajp.2009.09010093  1
2009 Gao XM, Elmer GI, Adams-Huet B, Tamminga CA. Social memory in mice: Disruption with an NMDA antagonist and attenuation with antipsychotic drugs Pharmacology Biochemistry and Behavior. 92: 236-242. PMID 19103218 DOI: 10.1016/J.Pbb.2008.11.016  1
2009 Casey DE, Daniel DG, Tamminga C, Kane JM, Tran-Johnson T, Wozniak P, Abi-Saab W, Baker J, Redden L, Greco N, Saltarelli M. Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1330-8. PMID 19052541 DOI: 10.1038/Npp.2008.209  1
2009 Uh J, Yezhuvath U, Mihalakos P, Tamminga C, Lu H. Perfusion Deficit in Schizophrenia and Correlation with Psychopathological Symptoms Neuroimage. 47. DOI: 10.1016/S1053-8119(09)71642-8  1
2008 Sellin AK, Shad M, Tamminga CA. Muscarinic agonists for the treatment of cognition in schizophrenia Cns Spectrums. 13: 985-996. PMID 19037177 DOI: 10.1017/S1092852900014048  1
2008 Tamminga CA. Accelerating new knowledge in schizophrenia American Journal of Psychiatry. 165: 949-951. PMID 18676597 DOI: 10.1176/Appi.Ajp.2008.08060815  0.01
2008 Krishnan V, Han MH, Mazei-Robison M, Iñiguez SD, Ables JL, Vialou V, Berton O, Ghose S, Covington HE, Wiley MD, Henderson RP, Neve RL, Eisch AJ, Tamminga CA, Russo SJ, et al. AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biological Psychiatry. 64: 691-700. PMID 18639865 DOI: 10.1016/J.Biopsych.2008.06.003  1
2008 Conn PJ, Tamminga C, Schoepp DD, Lindsley C. Schizophrenia: moving beyond monoamine antagonists. Molecular Interventions. 8: 99-107. PMID 18403654 DOI: 10.1124/Mi.8.2.7  1
2008 Green TA, Alibhai IN, Unterberg S, Neve RL, Ghose S, Tamminga CA, Nestler EJ. Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 2025-32. PMID 18305237 DOI: 10.1523/Jneurosci.5273-07.2008  1
2008 Tamminga CA, Michels R, Pine DS, Schultz SK, Lewis DA, Freedman R. 2008 in review American Journal of Psychiatry. 165: 1510-1513. DOI: 10.1176/Appi.Ajp.2008.08091434  1
2008 Castillo MA, Ghose S, Tamminga C, Ulery-Reynolds PG. Deficits In Ck2-Mediated Syntaxin 1 Phosphorylation In Schizophrenia Schizophrenia Research. 102: 221. DOI: 10.1016/S0920-9964(08)70668-6  1
2008 Ivleva E, Moates A, Cole D, Cheng P, Cullum M, Suppes T, Thaker G, Tamminga C. 5 – Neurophysiological and cognitive phenotypes across the schizophrenia–bipolar disorder boundary Schizophrenia Research. 98: 34-35. DOI: 10.1016/J.Schres.2007.12.072  1
2008 Ghose S, Tamminga CA. Alterations in hippocampal function in schizophrenia: Its genetic associations and systems implications Cortical Deficits in Schizophrenia: From Genes to Function. 157-190. DOI: 10.1007/978-0-387-74351-6_8  1
2007 Tamminga CA, Michels R, Pine DS, Schultz SK, Lewis DA, Freedman R. 2007 In review American Journal of Psychiatry. 164: 1780-1783. PMID 22688277 DOI: 10.1176/Appi.Ajp.2007.07101620  1
2007 Ivleva E, Thaker G, Tamminga CA. Comparing Genes and Phenomenology in the Major Psychoses: Schizophrenia and Bipolar 1 Disorder Schizophrenia Bulletin. 34: 734-742. PMID 18515820 DOI: 10.1093/Schbul/Sbn051  1
2007 Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, ... ... Tamminga CA, et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell. 131: 391-404. PMID 17956738 DOI: 10.1016/J.Cell.2007.09.018  1
2007 Shad MU, Keshavan MS, Tamminga CA, Cullum CM, David A. Neurobiological underpinnings of insight deficits in schizophrenia. International Review of Psychiatry (Abingdon, England). 19: 437-46. PMID 17671876 DOI: 10.1080/09540260701486324  1
2007 Geyer MA, Tamminga CA. Wayne Fenton's impact on academic neuroscience. Schizophrenia Bulletin. 33: 1156-9. PMID 17617663 DOI: 10.1093/Schbul/Sbm077  1
2007 Lahti RA, Tamminga CA, Carlsson A. Stimulating and inhibitory effects of the dopamine "stabilizer" (-)-OSU6162 on dopamine D2 receptor function in vitro. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 1143-6. PMID 17612788 DOI: 10.1007/S00702-007-0784-7  1
2007 Tamminga CA. Jon M Stolk, PhD, MD Neuropsychopharmacology. 32: 255-255. DOI: 10.1038/Sj.Npp.1301236  0.01
2006 Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA. Human postmortem tissue: what quality markers matter? Brain Research. 1123: 1-11. PMID 17045977 DOI: 10.1016/J.Brainres.2006.09.025  1
2006 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga C, Patterson SL, McIntyre JS, Goldman HH, Yudofsky SC, Hales RE, Rapaport MH, Hales D, Krajeski J, Kupfer DJ, et al. Conflict of interest, round 2. The American Journal of Psychiatry. 163: 1481-3. PMID 16946167 DOI: 10.1176/Appi.Ajp.163.9.1481  1
2006 Hayashi K, Pan Y, Shu H, Ohshima T, Kansy JW, White CL, Tamminga CA, Sobel A, Curmi PA, Mikoshiba K, Bibb JA. Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain. Journal of Neurochemistry. 99: 237-50. PMID 16925597 DOI: 10.1111/J.1471-4159.2006.04113.X  1
2006 Tamminga CA. Practical Treatment Information for Schizophrenia American Journal of Psychiatry. 163: 563-565. PMID 16585424 DOI: 10.1176/Appi.Ajp.163.4.563  0.01
2006 Erdely HA, Tamminga CA, Roberts RC, Vogel MW. Regional alterations in RGS4 protein in schizophrenia. Synapse (New York, N.Y.). 59: 472-9. PMID 16565965 DOI: 10.1002/Syn.20265  1
2006 Tamminga CA, Nestler EJ. Pathological gambling: focusing on the addiction, not the activity. The American Journal of Psychiatry. 163: 180-1. PMID 16449466 DOI: 10.1176/Appi.Ajp.163.2.180  1
2006 Gao XM, Cooper T, Suckow RF, Tamminga CA. Multidose Risperidone Treatment Evaluated in a Rodent Model of Tardive Dyskinesia Neuropsychopharmacology. 31: 1864-1868. PMID 16319911 DOI: 10.1038/Sj.Npp.1300975  1
2006 Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Carpenter WT, McMahon R. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 221-30. PMID 16123774 DOI: 10.1038/Sj.Npp.1300837  1
2006 Tamminga CA. HIV and AIDS American Journal of Psychiatry. 163: 1322-1322. DOI: 10.1176/Appi.Ajp.163.8.1322  0.01
2006 Tamminga CA. 2006 in review American Journal of Psychiatry. 163: 2037-2040. DOI: 10.1176/Appi.Ajp.163.12.2037  0.01
2006 Davis JM, Marder SR, Tamminga CA. Switch or Stay American Journal of Psychiatry. 163: 2032-2033. DOI: 10.1176/Appi.Ajp.163.12.2032  1
2005 Akbarian S, Ruehl MG, Bliven E, Luiz LA, Peranelli AC, Baker SP, Roberts RC, Bunney WE, Conley RC, Jones EG, Tamminga CA, Guo Y. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Archives of General Psychiatry. 62: 829-40. PMID 16061760 DOI: 10.1001/Archpsyc.62.8.829  1
2005 Holcomb HH, Lahti AC, Medoff DR, Cullen T, Tamminga CA. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2275-82. PMID 16034443 DOI: 10.1038/Sj.Npp.1300824  1
2005 Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Research. 139: 19-30. PMID 15950442 DOI: 10.1016/J.Pscychresns.2005.02.006  1
2005 LaPorte DJ, Blaxton TA, Michaelidis T, Robertson DU, Weiler MA, Tamminga CA, Lahti AC. Subtle effects of ketamine on memory when administered following stimulus presentation. Psychopharmacology. 180: 385-90. PMID 15719220 DOI: 10.1007/S00213-005-2179-5  1
2005 Tamminga CA, Holcomb HH. Phenotype of schizophrenia: a review and formulation. Molecular Psychiatry. 10: 27-39. PMID 15340352 DOI: 10.1038/Sj.Mp.4001563  1
2004 Tamminga CA, Buchsbaum MS. Frontal cortex function. The American Journal of Psychiatry. 161: 2178. PMID 15569885 DOI: 10.1176/appi.ajp.161.12.2178  1
2004 Tamminga C, Hashimoto T, Volk DW, Lewis DA. GABA neurons in the human prefrontal cortex. The American Journal of Psychiatry. 161: 1764. PMID 15465968 DOI: 10.1176/Ajp.161.10.1764  1
2004 Holcomb HH, Parwani A, McMahon RP, Medoff DR, Frey K, Lahti AC, Tamminga CA. Parametric study of accuracy and response time in schizophrenic persons making visual or auditory discriminations. Psychiatry Research. 127: 207-16. PMID 15296820 DOI: 10.1016/J.Psychres.2004.04.003  1
2004 Erdely HA, Lahti RA, Lopez MB, Myers CS, Roberts RC, Tamminga CA, Vogel MW. Regional expression of RGS4 mRNA in human brain. The European Journal of Neuroscience. 19: 3125-8. PMID 15182322 DOI: 10.1111/J.0953-816X.2004.03364.X  1
2004 Tamminga CA. Demonstrating drug action. American Journal of Psychiatry. 161: 943-945. PMID 15169679 DOI: 10.1176/Appi.Ajp.161.6.943  0.01
2004 Dwivedi Y, Rizavi HS, Shukla PK, Lyons J, Faludi G, Palkovits M, Sarosi A, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biological Psychiatry. 55: 234-43. PMID 14744463 DOI: 10.1016/J.Biopsych.2003.11.003  1
2004 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, Tamminga CA. Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 171-8. PMID 14520337 DOI: 10.1038/Sj.Npp.1300312  1
2004 Geyer MA, Tamminga CA. Measurement and treatment research to improve cognition in schizophrenia: neuropharmacological aspects Psychopharmacology. 174: 1-2. DOI: 10.1007/S00213-004-1846-2  1
2003 Kelly DL, Conley RR, Richardson CM, Tamminga CA, Carpenter WT. Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia. Annals of Clinical Psychiatry. 15: 181-186. PMID 14971863 DOI: 10.1023/B:Acli.0000008171.90644.F8  1
2003 Tamminga CA, Lahti AC, Medoff DR, Gao XM, Holcomb HH. Evaluating glutamatergic transmission in schizophrenia. Annals of the New York Academy of Sciences. 1003: 113-8. PMID 14684439 DOI: 10.1196/Annals.1300.062  1
2003 Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry. 60: 804-15. PMID 12912764 DOI: 10.1001/Archpsyc.60.8.804  1
2003 Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Roberts RC, Conley RR, Tamminga C. Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. Journal of Psychiatric Research. 37: 421-32. PMID 12849934 DOI: 10.1016/S0022-3956(03)00047-5  1
2003 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biological Psychiatry. 53: 601-8. PMID 12679238 DOI: 10.1016/S0006-3223(02)01602-5  1
2003 Dwivedi Y, Rao JS, Rizavi HS, Kotowski J, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Archives of General Psychiatry. 60: 273-82. PMID 12622660 DOI: 10.1001/Archpsyc.60.3.273  1
2002 Tamminga CA, Carlsson A. Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis Curr Drug Target Cns Neurol Disord. 1: 141-147. PMID 12769623 DOI: 10.2174/1568007024606195  1
2002 Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 499-517. PMID 12377388 DOI: 10.1016/S0893-133X(02)00335-4  1
2002 Tamminga CA, Nemeroff CB, Blakely RD, Brady L, Carter CS, Davis KL, Dingledine R, Gorman JM, Grigoriadis DE, Henderson DC, B Innis RB, Killen J, Laughren TP, McDonald WM, M Murphy GM, et al. Developing novel treatments for mood disorders: accelerating discovery. Biological Psychiatry. 52: 589-609. PMID 12361670 DOI: 10.1016/S0006-3223(02)01470-1  1
2002 Avila MT, Weiler MA, Lahti AC, Tamminga CA, Thaker GK. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. The American Journal of Psychiatry. 159: 1490-6. PMID 12202268 DOI: 10.1176/Appi.Ajp.159.9.1490  1
2002 Tamminga CA. Partial dopamine agonists in the treatment of psychosis Journal of Neural Transmission. 109: 411-420. PMID 11956961 DOI: 10.1007/S007020200033  0.01
2002 Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Pandey SC, Pesold C, Roberts RC, Conley RR, Tamminga CA. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. The American Journal of Psychiatry. 159: 419-29. PMID 11870006 DOI: 10.1176/Appi.Ajp.159.3.419  1
2002 Dwivedi Y, Conley RR, Roberts RC, Tamminga CA, Pandey GN. [(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. The American Journal of Psychiatry. 159: 66-73. PMID 11772692 DOI: 10.1176/Appi.Ajp.159.1.66  1
2002 Sherr JD, Thaker G, Tamminga CA. The prevention and management of tardive dyskinesia in the elderly Psychiatric Annals. 32: 237-243. DOI: 10.3928/0048-5713-20020401-08  1
2002 Tamminga CA, Medoff DR, Cooper AM. Diseases of the mind and brain American Journal of Psychiatry. 159: 917. DOI: 10.1176/Appi.Ajp.159.6.917  1
2002 Dwivedi Y, Risavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Erratum: mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims (Neuropsychopharmacology (October 2002) 27:4 (499-517) PII:S0893133X02003354) Neuropsychopharmacology. 27. DOI: 10.1016/S0893-133X(02)00441-4  1
2001 Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus. 11: 543-50. PMID 11732707 DOI: 10.1002/Hipo.1070  1
2001 Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. The American Journal of Psychiatry. 158: 1797-808. PMID 11691685 DOI: 10.1176/Appi.Ajp.158.11.1797  1
2001 Schwarcz R, Rassoulpour A, Wu HQ, Medoff D, Tamminga CA, Roberts RC. Increased cortical kynurenate content in schizophrenia. Biological Psychiatry. 50: 521-30. PMID 11600105 DOI: 10.1016/S0006-3223(01)01078-2  1
2001 Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 455-67. PMID 11557159 DOI: 10.1016/S0893-133X(01)00243-3  1
2001 Tamminga CA, Frost DO. Changing concepts in the neurochemistry of schizophrenia. American Journal of Psychiatry. 158: 1365-1366. PMID 11532717 DOI: 10.1176/Appi.Ajp.158.9.1365  0.01
2001 Brockman JA, Tamminga CA. The Human Genome: Microarray Expression Analysis American Journal of Psychiatry. 158: 1199-1199. PMID 11481149 DOI: 10.1176/Appi.Ajp.158.8.1199  0.01
2001 Holcomb HH, Lahti AC, Medoff DR, Weiler M, Tamminga CA. Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 165-72. PMID 11425500 DOI: 10.1016/S0893-133X(01)00229-9  1
2001 Lahti AC, Warfel D, Michaelidis T, Weiler MA, Frey K, Tamminga CA. Long-term outcome of patients who receive ketamine during research. Biological Psychiatry. 49: 869-75. PMID 11343683 DOI: 10.1016/S0006-3223(00)01037-4  1
2001 Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. Journal of Neurochemistry. 77: 916-28. PMID 11331420 DOI: 10.1046/J.1471-4159.2001.00300.X  1
2001 Tamminga CA. The Human Genome Sequence American Journal of Psychiatry. 158: 370-370. PMID 11229974 DOI: 10.1176/Appi.Ajp.158.3.370  0.01
2001 Sakai K, Gao X, Tamminga CA. Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats Psychopharmacology. 153: 191-195. PMID 11205418 DOI: 10.1007/S002130000570  1
2001 Patel JK, Caplan B, Green A, Tamminga C. First-episode psychosis: Critical management issues during the first two years Harvard Review of Psychiatry. 9: 33-41. PMID 11159931 DOI: 10.1080/10673220127872  1
2001 Tamminga CA, Holcomb HH. Neural networks: neural systems vi: basal ganglia. American Journal of Psychiatry. 158: 185-185. PMID 11156797 DOI: 10.1176/Appi.Ajp.158.2.185  1
2000 Weiler MA, Thaker GK, Lahti AC, Tamminga CA. Ketamine effects on eye movements. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 645-53. PMID 11063920 DOI: 10.1016/S0893-133X(00)00156-1  1
2000 Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. The American Journal of Psychiatry. 157: 1634-45. PMID 11007718 DOI: 10.1176/Appi.Ajp.157.10.1634  1
2000 Buckley PF, Buchanan RW, Tamminga CA, Schulz SC. Schizophrenia Research: A Progress Report, Summarizing Proceedings of the 1999 International Congress on Schizophrenia Research Schizophrenia Bulletin. 26: 411-419. PMID 10885640 DOI: 10.1093/Oxfordjournals.Schbul.A033462  1
2000 Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. The American Journal of Psychiatry. 157: 1141-9. PMID 10873924 DOI: 10.1176/Appi.Ajp.157.7.1141  1
2000 Tamminga CA, Vogel M, Gao X, Lahti AC, Holcomb HH. The limbic cortex in schizophrenia: focus on the anterior cingulate. Brain Research. Brain Research Reviews. 31: 364-70. PMID 10719164 DOI: 10.1016/S0165-0173(99)00053-3  1
2000 Tamminga CA, Shadmehr R, Holcomb HH. Images in neuroscience. Cognition: procedural memory. The American Journal of Psychiatry. 157: 162. PMID 10671381 DOI: 10.1176/Appi.Ajp.157.2.162  1
2000 Tamminga CA. New" rather than "atypical". Psychopharmacology. 148: 20-21. PMID 10663412 DOI: 10.1007/S002130050019  0.01
1999 Kelly DL, Conley RR, Tamminga CA. Differential olanzapine plasma concentrations by sex in a fixed-dose study Schizophrenia Research. 40: 101-104. PMID 10593449 DOI: 10.1016/S0920-9964(99)00053-5  1
1999 Pandey GN, Dwivedi Y, Pandey SC, Teas SS, Conley RR, Roberts RC, Tamminga CA. Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta1 protein in the prefrontal cortex of teenage suicide subjects. The American Journal of Psychiatry. 156: 1895-901. PMID 10588402 DOI: 10.1176/Ajp.156.12.1895  1
1999 Lahti RA, Tamminga CA. Effect of amphetamine, α-methyl-p-tyrosine (α-MPT) and antipsychotic agents on dopamine D2-type receptor occupancy in rats Progress in Neuro-Psychopharmacology & Biological Psychiatry. 23: 1277-1283. PMID 10581648 DOI: 10.1016/S0278-5846(99)00064-0  1
1999 Conley RR, Tamminga CA, Kelly DL, Richardson CM. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response Biological Psychiatry. 46: 73-77. PMID 10394475 DOI: 10.1016/S0006-3223(99)00029-3  1
1999 Truffinet P, Tamminga CA, Fabre LF, Meltzer HY, Rivière ME, Papillon-Downey C. Placebo-controlled study of the D4/5-HT2A antagonist fananserin in the treatment of schizophrenia. The American Journal of Psychiatry. 156: 419-25. PMID 10080558 DOI: 10.1176/Ajp.156.3.419  0.01
1999 Tamminga CA. Glutamatergic aspects of schizophrenia. The British Journal of Psychiatry. Supplement. 174: 12-15. DOI: 10.1192/S0007125000293598  0.01
1999 Lahti AC, Holcomb HH, Gao XM, Tamminga CA. NMDA-sensitive glutamate antagonism: A human model for psychosis Neuropsychopharmacology. 21: S158-S169. DOI: 10.1016/S0924-977X(00)80125-X  1
1998 Lahti RA, Roberts RC, Cochrane EV, Primus RJ, Gallager DW, Conley RR, Tamminga CA. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study. Molecular Psychiatry. 3: 528-33. PMID 9857979 DOI: 10.1038/Sj.Mp.4000423  1
1998 Buchanan RW, Buckley PF, Tamminga CA, Schulz SC. Schizophrenia Research: A Biennium of Progress Proceedings From the Sixth International Congress on Schizophrenia Research Schizophrenia Bulletin. 24: 501-518. PMID 9853785 DOI: 10.1093/Oxfordjournals.Schbul.A033345  1
1998 Lahti AC, Weiler M, Carlsson A, Tamminga CA. Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 719-34. PMID 9826114 DOI: 10.1007/S007020050091  1
1998 Holcomb HH, Medoff DR, Caudill PJ, Zhao Z, Lahti AC, Dannals RF, Tamminga CA. Cerebral blood flow relationships associated with a difficult tone recognition task in trained normal volunteers. Cerebral Cortex (New York, N.Y. : 1991). 8: 534-42. PMID 9758216 DOI: 10.1093/Cercor/8.6.534  1
1998 Lahti RA, Cochrane EV, Roberts RC, Conley RR, Tamminga CA. [3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 507-16. PMID 9720978 DOI: 10.1007/S007020050074  1
1998 Brainard MS, Knudsen EI. Images in neuroscience. Brain development, V: Experience affects brain development. The American Journal of Psychiatry. 155: 1000. PMID 9699684 DOI: 10.1176/Ajp.155.8.1000  1
1998 Conley RR, Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, Hegerty J, Love R, Gounaris C, Zaremba S. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. The American Journal of Psychiatry. 155: 914-20. PMID 9659857 DOI: 10.1176/Ajp.155.7.914  1
1998 Hashimoto T, Ross DE, Gao XM, Medoff DR, Tamminga CA. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia. Psychopharmacology. 137: 107-112. PMID 9629996 DOI: 10.1007/S002130050599  1
1998 Tamminga CA. Schizophrenia and glutamatergic transmission. Critical Reviews in Neurobiology. 12: 21-36. PMID 9444480 DOI: 10.1615/Critrevneurobiol.V12.I1-2.20  0.01
1998 Lahti AC, Weiler MA, Corey PK, Lahti RA, Carlsson A, Tamminga CA. Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biological Psychiatry. 43: 2-11. PMID 9442338 DOI: 10.1016/S0006-3223(97)00030-9  1
1998 Zimbroff DL, Kane JM, Tamminga CA. Dr. Zimbroff and Colleagues Reply American Journal of Psychiatry. 155. DOI: 10.1176/Ajp.155.9.1303B  1
1998 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Kile L, Michaelidis T, Fletcher S, Tamminga CA. Time course of rCBF changes after acute haloperidol in patients with schizophrenia Neuroimage. 7: S245. DOI: 10.1016/S1053-8119(18)31078-4  1
1997 Tamminga CA, Kane JM. Olanzapine (Zyprexa):characteristics of a new antipsychotic. Expert Opinion On Investigational Drugs. 6: 1743-1752. PMID 15989578 DOI: 10.1517/13543784.6.11.1743  1
1997 Kane JM, Tamminga CA. Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychotic Expert Opinion On Investigational Drugs. 6: 1729-1741. PMID 15989577 DOI: 10.1517/13543784.6.11.1729  1
1997 Maeda K, Kaneda H, Whetsell WO, Tamminga CA. Neurochemical and metabolic consequences of elevated cerebrospinal fluid quinolinic acid concentrations in rat brain. Neuroscience Research. 29: 303-9. PMID 9527621 DOI: 10.1016/S0168-0102(97)00102-8  1
1997 Conley RR, Carpenter WT, Tamminga CA. Time to clozapine response in a standardized trial American Journal of Psychiatry. 154: 1243-1247. PMID 9286183 DOI: 10.1176/Ajp.154.9.1243  1
1997 Pandey GN, Conley RR, Pandey SC, Goel S, Roberts RC, Tamminga CA, Chute D, Smialek J. Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects. Psychiatry Research. 71: 137-49. PMID 9271787 DOI: 10.1016/S0165-1781(97)00060-7  1
1997 Kelley JJ, Gao XM, Tamminga CA, Roberts RC. The effect of chronic haloperidol treatment on dendritic spines in the rat striatum. Experimental Neurology. 146: 471-8. PMID 9270058 DOI: 10.1006/Exnr.1997.6552  1
1997 Pandey GN, Dwivedi Y, Pandey SC, Conley RR, Roberts RC, Tamminga CA. Protein kinase C in the postmortem brain of teenage suicide victims. Neuroscience Letters. 228: 111-4. PMID 9209111 DOI: 10.1016/S0304-3940(97)00378-9  1
1997 Tamminga CA, Mack RJ, Granneman GR, Silber CJ, Kashkin KB. Sertindole in the treatment of psychosis in schizophrenia: Efficacy and safety International Clinical Psychopharmacology. 12. PMID 9179641 DOI: 10.1097/00004850-199702001-00005  1
1997 Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, Sebree TB, Wallin BA, Kashkin KB. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia American Journal of Psychiatry. 154: 782-791. PMID 9167505 DOI: 10.1176/Ajp.154.6.782  1
1997 Tamminga CA. The promise of new drugs for schizophrenia treatment. The Canadian Journal of Psychiatry. 42: 265-273. PMID 9114942 DOI: 10.1177/070674379704200304  0.01
1997 Gao XM, Hashimoto T, Cooper TB, Tamminga CA. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration. Journal of Neural Transmission. 104: 97-104. PMID 9085197 DOI: 10.1007/Bf01271298  1
1997 LaPorte D, Lahti A, Hagedorn H, Corey T, Tamminga C. Effecfs of monetary reinforcement on verbal and visuospatial memory in schizophrenic subjects Schizophrenia Research. 24: 112-113. DOI: 10.1016/S0920-9964(97)82314-6  1
1997 Conley R, Richardson C, Tamminga C. Treatment of primary negative symptoms Biological Psychiatry. 42: 2-4. DOI: 10.1016/S0006-3223(97)87753-0  1
1996 LaPorte DJ, Lahti AC, Koffel B, Tamminga CA. Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients. Journal of Psychiatric Research. 30: 321-30. PMID 8923336 DOI: 10.1016/0022-3956(96)00018-0  1
1996 Lahti RA, Roberts RC, Conley RR, Cochrane EV, Mutin A, Tamminga CA. D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects. Neuroreport. 7: 1945-8. PMID 8905699 DOI: 10.1097/00001756-199608120-00016  1
1996 Gao XM, Tamminga CA. Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time course. Synapse. 23: 274-279. PMID 8855512 DOI: 10.1002/(Sici)1098-2396(199608)23:4<274::Aid-Syn5>3.0.Co;2-4  1
1996 Tamminga CA, Lahti AC. The new generation of antipsychotic drugs. International Clinical Psychopharmacology. 11: 73-6. PMID 8803664 DOI: 10.1097/00004850-199605002-00012  1
1996 Lahti RA, Mutin A, Cochrane EV, Tepper PG, Dijkstra D, Wikström H, Tamminga CA. Affinities and intrinsic activities of dopamine receptor agonists for the hD21 and hD4.4 receptors. European Journal of Pharmacology. 301: 11-13. PMID 8773470 DOI: 10.1016/0014-2999(96)00127-6  1
1996 Buckley PF, Buchanan RW, Schulz SC, Tamminga CA. Catching up on schizophrenia. The Fifth International Congress on Schizophrenia Research, Warm Springs, Va, April 8-12, 1995. Archives of General Psychiatry. 53: 456-462. PMID 8624189 DOI: 10.1001/Archpsyc.1996.01830050092014  1
1996 Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry. 153: 41-49. PMID 8540590 DOI: 10.1176/Ajp.153.1.41  1
1996 Tamminga C, Mack R, Zborowski J, Morris D, Sebree T, Wallin B. Efficacy and safety of three doses of sertindole and haldol in schizophrenic patients European Neuropsychopharmacology. 6: 61. DOI: 10.1016/0924-977X(96)87584-5  1
1995 Tamminga CA, Holcomb HH, Gao XM, Lahti AC. Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. International Clinical Psychopharmacology. 10: 29-37. PMID 8866763 DOI: 10.1097/00004850-199509000-00005  1
1995 Lahti RA, Roberts RC, Tamminga CA. D2-family receptor distribution in human postmortem tissue: an autoradiographic study. Neuroreport. 6: 2505-12. PMID 8741751 DOI: 10.1097/00001756-199512150-00015  1
1995 Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 13: 9-19. PMID 8526975 DOI: 10.1016/0893-133X(94)00131-I  1
1995 Holcomb HH, Boatman D, Tamminga CA. Images in neuroscience. Cortex, VI. Auditory cortical function. American Journal of Psychiatry. 152: 504. PMID 7900927 DOI: 10.1176/Ajp.152.4.504  1
1995 Carpenter WT, Tamminga CA. Why Neuroleptic Withdrawal in Schizophrenia Archives of General Psychiatry. 52: 192-193. PMID 7872843 DOI: 10.1001/Archpsyc.1995.03950150024003  1
1995 Weinberger DR, Goldberg TE, Tamminga CA. Images in neuroscience: Prefrontal leukotomy American Journal of Psychiatry. 152: 330-331. PMID 7864256 DOI: 10.1176/Ajp.152.3.330  1
1995 Shenton ME, McCarley RW, Tamminga CA. Cortex, IX. Heschl's gyrus and the planum temporale. The American Journal of Psychiatry. 152: 966. PMID 7793465 DOI: 10.1176/Ajp.152.7.966  0.01
1995 Carpenter WT, Conley RR, Buchanan RW, Breier A, Tamminga CA. Patient response and resource management: another view of clozapine treatment of schizophrenia. The American Journal of Psychiatry. 152: 827-32. PMID 7755110 DOI: 10.1176/Ajp.152.6.827  1
1995 Lahti AC, Tamminga CA. Recent developments in the neuropharmacology of schizophrenia. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 52: S5-8. PMID 7749964 DOI: 10.1093/Ajhp/52.3_Suppl_1.S5  1
1995 Sloviter RS, Tamminga CA. Images in neuroscience. The hippocampus in epilepsy. The American Journal of Psychiatry. 152: 659. PMID 7726303 DOI: 10.1176/Ajp.152.5.659  1
1995 Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport. 6: 869-72. PMID 7612873 DOI: 10.1097/00001756-199504190-00011  1
1995 Roberts RC, Gaither LA, Gao XM, Kashyap SM, Tamminga CA. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum. Synapse (New York, N.Y.). 20: 234-43. PMID 7570355 DOI: 10.1002/Syn.890200307  1
1995 Holcomb HH, Ritzl EK, Medoff DR, Nevitt J, Gordon B, Tamminga CA. Tone discrimination performance in schizophrenic patients and normal volunteers: impact of stimulus presentation levels and frequency differences. Psychiatry Research. 57: 75-82. PMID 7568562 DOI: 10.1016/0165-1781(95)02270-7  1
1995 Murphy GM, Tamminga CA. Cortex, XI. Amyloid plaques. American Journal of Psychiatry. 152: 1258. PMID 7544545 DOI: 10.1176/Ajp.152.9.1258  0.01
1995 Holcomb HH, Tamminga CA. Images in neuroscience. Neuroimaging, II. Regional cerebral blood flow with H2(15)O. American Journal of Psychiatry. 152: 1563. PMID 7485617 DOI: 10.1176/Ajp.152.11.1563A  1
1995 Grafman J, Tamminga CA. Cortex, IV; Regional Cerebral Blood Flow American Journal of Psychiatry. 152: 163-163. DOI: 10.1176/Ajp.152.2.163  0.01
1995 Holcomb HH, Tamminga CA. Neuroimaging, II; Regional Cerebral Blood Flow With H215O American Journal of Psychiatry. 152: 1562-1562. DOI: 10.1176/Ajp.152.11.1562  1
1995 SELEMON LD, GOLDMAN-RAKIC PS, TAMMINGA CA. Corex, III; Prefrontal Cortex American Journal of Psychiatry. 152: 5-5. DOI: 10.1176/Ajp.152.1.5  0.01
1995 Lahti RA, Lahti AC, Tamminga CA, Ranhosky, Kleber HD, Wise RA, Sethy. D2-family receptors in schizophrenia: Distribution and implications for treatment Clinical Neuropharmacology. 18: S110-S120. DOI: 10.1097/00002826-199501001-00013  1
1995 Conley R, Daviss S, Gounaris C, Tamminga C. Cavum septum pellucidum (CSP) in treatment resistant schizophrenia Schizophrenia Research. 15: 26. DOI: 10.1016/0920-9964(95)95092-N  1
1995 Zborowski J, Schmitz P, Staser J, O'Neil J, Giles K, Wallin B, Sebree T, Tamminga C. Efficacy and safety of sertindole in a trial of schizophrenic patients Biological Psychiatry. 37: 661-662. DOI: 10.1016/0006-3223(95)94656-H  1
1994 Tamminga CA, Roberts RC. Human brain receptors. Electron micrograph of human striatum showing synaptic structures. The American Journal of Psychiatry. 151: 177. PMID 8296884 DOI: 10.1176/Ajp.151.2.177  1
1994 Meador-Woodruff JH, Watson SJ, Tamminga CA. Human brain receptors,V. Binding and message. The American Journal of Psychiatry. 151: 804. PMID 8184989 DOI: 10.1176/Ajp.151.6.804  1
1994 Tamminga CA, Dahl SG. Human brain receptors, III. Molecular Model: G protein-coupled receptor. American Journal of Psychiatry. 151: 499. PMID 8147446 DOI: 10.1176/Ajp.151.4.499  0.01
1994 Tamminga CA. Human brain receptors, II: G Protein-coupled receptors American Journal of Psychiatry. 151: 342-342. PMID 8109641 DOI: 10.1176/Ajp.151.3.342  0.01
1994 Gao XM, Tamminga CA. Human brain receptors, VIII. The distribution of ionotropic glutamate receptors in the human hippocampus. American Journal of Psychiatry. 151: 1271. PMID 8067479 DOI: 10.1176/Ajp.151.9.1271  1
1994 Shepard PD, Tamminga CA. Images in neuroscience. Human Brain receptors, VI. Ionotropic receptors. The American Journal of Psychiatry. 151: 956. PMID 8010380 DOI: 10.1176/Ajp.151.7.956  1
1994 Conley R, Tamminga CA, Nguyen JA. Clinical Action of Remoxipride Archives of General Psychiatry. 51: 1001-1001. PMID 7979877 DOI: 10.1001/Archpsyc.1994.03950120073012  1
1994 Andreasen NC, Tamminga CA. Images in neuroscience. Cortex,II: identifying lobes and landmarks. The American Journal of Psychiatry. 151: 1722. PMID 7977876 DOI: 10.1176/Ajp.151.12.1722  0.01
1994 Cascella NG, Tarazi FI, Shirakawa O, Tamminga CA. Savoxepine fails to selectively influence glucose metabolism in the rat limbic system Psychopharmacology. 114: 275-280. PMID 7838920 DOI: 10.1007/Bf02244849  1
1994 Carpenter WT, Buchanan RW, Kirkpatrick B, Tamminga C, Wood F. Neural Circuits in Schizophrenia-Reply Archives of General Psychiatry. 51: 516. DOI: 10.1001/Archpsyc.1994.03950070008004  1
1994 Shepard PD, Tamminga CA. Human brain receptors, VI: Ionotropic receptors American Journal of Psychiatry. 151: 956.  1
1993 Holcomb HH, Cascella NG, Medoff DR, Gastineau EA, Loats H, Thaker GK, Conley RR, Dannals RF, Wagner HN, Tamminga CA. PET-FDG test-retest reliability during a visual discrimination task in schizophrenia Journal of Computer Assisted Tomography. 17: 704-709. PMID 8370824 DOI: 10.1097/00004728-199309000-00007  1
1993 Gao X, Shirakawa O, Du F, Tamminga CA. Delayed regional metabolic actions of phencyclidine European Journal of Pharmacology. 241: 7-15. PMID 8223927 DOI: 10.1016/0014-2999(93)90926-9  1
1993 Carpenter WT, Buchanan RW, Kirkpatrick B, Tamminga C, Wood F. Strong inference, theory testing, and the neuroanatomy of schizophrenia Archives of General Psychiatry. 50: 825-831. PMID 8215806 DOI: 10.1001/Archpsyc.1993.01820220081009  1
1993 Tarazi FI, Shirakawa O, Tamminga CA. Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects. European Journal of Pharmacology. 232: 71-77. PMID 8096189 DOI: 10.1016/0014-2999(93)90730-6  1
1993 Conley R, Tamminga C, Nguyen JA, Hain R. Remoxipride therapy in treatment resistant schizophrenia Schizophrenia Research. 9: 235-236. DOI: 10.1016/0920-9964(93)90521-J  1
1993 Conley R, Schmitt R, Peretti F, Smialek J, Tamminga C. Serotonin binding sites in the brain of schizophrenic suicide victims Schizophrenia Research. 9: 216. DOI: 10.1016/0920-9964(93)90465-U  1
1992 Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry. 49: 522-30. PMID 1627043 DOI: 10.1001/Archpsyc.1992.01820070016003  1
1992 Kaneda H, Shirakawa O, Dale J, Goodman L, Bachus SE, Tamminga CA. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats. European Journal of Pharmacology. 212: 43-9. PMID 1555638 DOI: 10.1016/0014-2999(92)90070-K  1
1992 Kirkpatrick B, Carpenter WT, Maeda K, Buchanan RW, Breier A, Tamminga CA. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients. Biological Psychiatry. 32: 1049-54. PMID 1467385 DOI: 10.1016/0006-3223(92)90067-A  1
1992 Pandey GN, Conley RR, Pandey SC, Tamminga C, Peretti F, Davis JM. Postmortem Brain 5Ht2 Receptors In Schizophrenia: Effect Of Neuroleptics And Suicide Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00103  1
1991 Carpenter WT, Buchanan RW, Breier A, Kirkpatrick B, Thaker G, Tamminga C. Psychopathology and the question of neurodevelopmental or neurodegenerative disorder. Schizophrenia Research. 5: 192-4. PMID 1760390 DOI: 10.1016/0920-9964(91)90067-2  1
1991 Bean AJ, Elde R, Cao Y, Oellig C, Tamminga C, Goldstein M, Pettersson RF, Hökfelt T. Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human Proceedings of the National Academy of Sciences of the United States of America. 88: 10237-10241. PMID 1719552 DOI: 10.1073/Pnas.88.22.10237  1
1991 Thaker G, Moran M, Cassady S, Adami H, Tamminga C. Normal Smooth Pursuit Eye Movements in Volunteer Subjects Meeting Schizotypal Personality Disorder Criteria American Journal of Psychiatry. 148: 1096-1097. DOI: 10.1176/Ajp.148.8.1096-B  1
1991 Conley R, Schmitt R, Pandy G-, Peretti F, Smialek J, Tamminga C. Serotonin binding sites and metabolites in the brain of schizophrenic suicide victims Schizophrenia Research. 4: 376-377. DOI: 10.1016/0920-9964(91)90309-F  1
1991 Conley R, Dixon L, Nguyen JA, Tamminga C, Raymond R. Remoxipride therapy in poorly responsive schizophrenics Schizophrenia Research. 4: 316. DOI: 10.1016/0920-9964(91)90208-9  1
1991 Dixon L, Thaker G, Cascella N, Conley R, Yablonski M, Tamminga C. Time course of psychopathologic and dyskinetic motor changes after blind neuroleptic withdrawal Schizophrenia Research. 4: 288. DOI: 10.1016/0920-9964(91)90161-J  1
1991 Conley R, Nguyen JA, Tamminga C. Haloperidol kinetics and clinical response Schizophrenia Research. 4: 287. DOI: 10.1016/0920-9964(91)90160-S  1
1990 Thaker GK, Moran M, Tamminga CA. GABAmimetics: A New Class of Antidepressant Agents? Archives of General Psychiatry. 47: 287-288. PMID 2306168 DOI: 10.1001/Archpsyc.1990.01810150087013  1
1990 Thaker GK, Moran M, Lahti A, Adami H, Tamminga C. Psychiatric Morbidity in Research Volunteers Archives of General Psychiatry. 47: 980. PMID 2222138 DOI: 10.1001/Archpsyc.1990.01810220096020  1
1990 Tamminga CA, Dale JM, Goodman L, Kaneda H, Kaneda N. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology. 102: 474-478. PMID 1982902 DOI: 10.1007/Bf02247127  1
1990 Thaker GK, Nguyen JA, Strauss ME, Jacobson R, Kaup BA, Tamminga CA. Clonazepam treatment of tardive dyskinesia: A practical GABAmimetic strategy American Journal of Psychiatry. 147: 445-451. PMID 1969244 DOI: 10.1176/Ajp.147.4.445  1
1990 Dixon L, Thakar G, Cascella N, Yablonski M, Tamminga C. Differing time course of emergence of psychotic symptoms and dyskinesia after neuroleptic withdrawal Schizophrenia Research. 3: 78-79. DOI: 10.1016/0920-9964(90)90180-F  1
1989 Thaker GK, Nguyen JA, Tamminga CA. Saccadic distractibility in schizophrenic patients with tardive dyskinesia. Archives of General Psychiatry. 46: 755-756. PMID 2568826 DOI: 10.1001/Archpsyc.1989.01810080085012  1
1989 Lahti A, Thaker G, Birt A, Elsberry R, Tamminga C. GABA hypothesis of tardive dyskinesia: clinical neurochemistry and neurophysiology Schizophrenia Research. 2: 237. DOI: 10.1016/0920-9964(89)90273-9  1
1989 Schulz SC, Tamminga C. The second international congress on schizophrenia research. San Diego, California, April 1-5, 1989 Schizophrenia Research. 2: 2. DOI: 10.1016/0920-9964(89)90038-8  1
1988 Pomara N, Stanley M, Rhiew HB, Bagne CA, Deptula D, Galloway MP, Tanimoto K, Verebey K, Tamminga CA. Loss of the cortisol response to naltrexone in Alzheimer's disease. Biological Psychiatry. 23: 726-33. PMID 3285899 DOI: 10.1016/0006-3223(88)90057-1  1
1988 Schwarcz R, Tamminga CA, Kurlan R, Shoulson I. Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia. Annals of Neurology. 24: 580-2. PMID 2977086 DOI: 10.1002/Ana.410240417  1
1988 Fabbrini G, Braun A, Mouradian MM, Tamminga CA, Chase TN. Dopamine D-1 receptor agonist stimulation of prolactin secretion in man. Journal of Neural Transmission. 71: 159-63. PMID 2965754 DOI: 10.1007/Bf01245709  1
1988 Tamminga CA, Burrows GH, Chase TN, Alphs LD, Thaker GK. Dopamine neuronal tracts in schizophrenia: their pharmacology and in vivo glucose metabolism. Annals of the New York Academy of Sciences. 537: 443-50. PMID 2904785 DOI: 10.1111/J.1749-6632.1988.Tb42126.X  1
1988 Kirkpatrick B, Tamminga CA. The endocrinology of extrapyramidal system disorders. Endocrinology and Metabolism Clinics of North America. 17: 159-172. DOI: 10.1016/S0889-8529(18)30439-0  1
1988 Kirkpatrick B, Tamminga CA. The endocrinology of extrapyramidal system disorders Neurologic Clinics. 6: 159-172. DOI: 10.1016/S0733-8619(18)30890-9  1
1987 Tamminga CA, Tanimoto K, Kuo S, Beck M, Chase TN. Central cholecystokinin octapeptide reduces glucose utilization in subcortical but not cortical rat brain. European Journal of Pharmacology. 139: 237-41. PMID 3653246 DOI: 10.1016/0014-2999(87)90257-3  1
1987 Tanimoto K, Tamminga CA, Chase TN. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats. European Journal of Pharmacology. 144: 147-51. PMID 3325296 DOI: 10.1016/0014-2999(87)90513-9  1
1987 Tanimoto K, Tamminga CA, Chase TN, Nilaver G. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide. Endocrinology. 121: 127-32. PMID 3297634 DOI: 10.1210/Endo-121-1-127  1
1987 Siever LJ, Tamminga CA, Pert A. Increased growth hormone response to clonidine in 6-hydroxydopamine-treated rats. Psychopharmacology. 91: 342-344. PMID 3104956 DOI: 10.1007/Bf00518188  0.01
1987 Thaker GK, Tamminga CA, Alphs LD, Lafferman J, Ferraro TN, Hare TA. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. Archives of General Psychiatry. 44: 522-9. PMID 3034188 DOI: 10.1001/Archpsyc.1987.01800180032006  1
1987 Tamminga CA, Foster NL, Fedio P, Bird ED, Chase TN. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism. Neurology. 37: 161-5. PMID 2879258 DOI: 10.1212/Wnl.37.1.161  1
1987 Tamminga CA, Tanimoto K, Kuo S, Chase TN, Contreras PC, Rice KC, Jackson AE, O'Donohue TL. PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent. Synapse (New York, N.Y.). 1: 497-504. PMID 2850626 DOI: 10.1002/Syn.890010514  1
1986 Foster NL, Tamminga CA, O'Donohue TL, Tanimoto K, Bird ED, Chase TN. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease. Neuroscience Letters. 63: 71-5. PMID 3754039 DOI: 10.1016/0304-3940(86)90015-7  1
1986 Tamminga CA, Littman RL, Alphs LD, Chase TN, Thaker GK, Wagman AM. Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies. Psychopharmacology. 88: 387-91. PMID 3083460 DOI: 10.1007/Bf00180843  1
1986 Wong DF, Wagner HN, Tune LE, Dannals RF, Pearlson GD, Links JM, Tamminga CA, Broussolle EP, Ravert HT, Wilson AA, Toung JK, Malat J, Williams JA, O'Tuama LA, Snyder SH, et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science (New York, N.Y.). 234: 1558-63. PMID 2878495 DOI: 10.1126/Science.2878495  1
1986 Shults C, Steardo L, Barone P, Mohr E, Juncos J, Serrati C, Fedio P, Tamminga CA, Chase TN. Huntington's disease: effect of cysteamine, a somatostatin-depleting agent. Neurology. 36: 1099-102. PMID 2874527 DOI: 10.1212/Wnl.36.8.1099  1
1986 Mohr E, Bruno G, Foster N, Gillespie M, Cox C, Hare TA, Tamminga C, Fedio P, Chase TN. GABA-agonist therapy for Alzheimer's disease. Clinical Neuropharmacology. 9: 257-63. PMID 2872956 DOI: 10.1097/00002826-198606000-00004  1
1986 Tamminga CA, Gotts MD, Thaker GK, Alphs LD, Foster NL. Dopamine Agonist Treatment of Schizophrenia With N-Propylnorapomorphine Archives of General Psychiatry. 43: 398-402. PMID 2869745 DOI: 10.1001/Archpsyc.1986.01800040108015  1
1985 Cohen SL, Knight M, Tamminga CA, Chase TN. A comparison of peripheral and central effects of CCK8 on water-reinforced operant responding. European Journal of Pharmacology. 116: 229-38. PMID 4076337 DOI: 10.1016/0014-2999(85)90157-8  1
1985 Steardo L, Monteleone P, Tamminga CA, Canonico PL, Denman D, Scapagnini U, Chase TN. Differential responses in prolactin levels induced by naloxone in humans. Psychoneuroendocrinology. 10: 203-9. PMID 4034850 DOI: 10.1016/0306-4530(85)90058-7  1
1985 Tamminga CA, LeWitt PA, Chase TN. Cholecystokinin and neurotensin gradients in human CSF. Archives of Neurology. 42: 354-5. PMID 3985812 DOI: 10.1001/Archneur.1985.04060040064013  1
1985 Bruno G, Ruggieri S, Chase TN, Bakker K, Tamminga CA. Caerulein treatment of Parkinson's disease. Clinical Neuropharmacology. 8: 266-70. PMID 3899353 DOI: 10.1097/00002826-198509000-00007  1
1985 Steardo L, Knight M, Tamminga CA, Barone P, Kask AM, Chase TN. CCK26-33 degrading activity in brain and nonneural tissue: a metalloendopeptidase. Journal of Neurochemistry. 45: 784-90. PMID 3897456 DOI: 10.1111/J.1471-4159.1985.Tb04061.X  1
1985 Chase TN, Barone P, Bruno G, Cohen SL, Juncos J, Knight M, Ruggeri S, Steardo L, Tamminga CA. Cholecystokinin-mediated synaptic function and the treatment of neuropsychiatric disease. Annals of the New York Academy of Sciences. 448: 553-61. PMID 3896100 DOI: 10.1111/J.1749-6632.1985.Tb29948.X  1
1985 Newman RP, Tamminga CA, Chase TN, LeWitt PA. EMD 23,448: effects of a putative dopamine autoreceptor agonist in chorea. Journal of Neural Transmission. 61: 125-9. PMID 3156964 DOI: 10.1007/Bf01253057  1
1985 Knight M, Barone P, Tamminga CA, Steardo L, Chase TN. Cholecystokinin octapeptide analogues stable to brain proteolysis. Peptides. 6: 631-4. PMID 2999729 DOI: 10.1016/0196-9781(85)90165-2  1
1985 Steardo L, Knight M, Tamminga CA, Chase TN. Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors. Neuroscience Letters. 54: 319-25. PMID 2986058 DOI: 10.1016/S0304-3940(85)80098-7  1
1985 Tamminga CA, Foster NL, Chase TN. Reduced brain somatostatin levels in Alzheimer's disease. The New England Journal of Medicine. 313: 1294-5. PMID 2865676 DOI: 10.1056/Nejm198511143132017  1
1985 Tamminga CA, Lucignani G, Porrino LJ, Chase TN. Cholecystokinin Octapeptide's Effect on Local Cerebral Glucose Utilization in the Laboratory Rat Annals of the New York Academy of Sciences. 448: 663-665. DOI: 10.1111/J.1749-6632.1985.Tb29981.X  1
1985 Schaffer MH, Davis JM, Tamminga CA. Apomorphine's Antipsychotic Activity Archives of General Psychiatry. 42: 927-928. DOI: 10.1001/Archpsyc.1985.01790320099017  1
1984 Knight M, Tamminga CA, Ito Y, Gardner JD, Chase TN. Purification of a cholecystokinin fragment peptide in the horizontal flow-through coil planet centrifuge. Journal of Chromatography. 301: 277-81. PMID 6501491 DOI: 10.1016/S0021-9673(01)89198-6  1
1984 Waszczak BL, Lee EK, Tamminga CA, Walters JR. Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 4: 2369-75. PMID 6434704 DOI: 10.1523/Jneurosci.04-09-02369.1984  1
1984 Gardner JD, Knight M, Sutliff VE, Tamminga CA, Jensen RT. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini American Journal of Physiology-Gastrointestinal and Liver Physiology. 246. PMID 6199984 DOI: 10.1152/Ajpgi.1984.246.3.G292  1
1984 Knight M, Tamminga CA, Steardo L, Beck ME, Barone P, Chase TN. Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors. European Journal of Pharmacology. 105: 49-55. PMID 6092115 DOI: 10.1016/0014-2999(84)90647-2  1
1984 Lucignani G, Porrino LJ, Tamminga CA. Effects of systemically administered cholecystokinin-octapeptide on local cerebral metabolism. European Journal of Pharmacology. 101: 147-51. PMID 6086359 DOI: 10.1016/0014-2999(84)90041-4  1
1984 Knight M, Kask AM, Tamminga CA. Purification of Solid-Phase Synthesized Peptides on the Coil Planet Centrifuge Journal of Liquid Chromatography & Related Technologies. 7: 351-362. DOI: 10.1080/01483918408073972  1
1983 Thaker GK, Hare TA, Tamminga CA. GABA system: clinical research and treatment of tardive dyskinesia. Modern Problems of Pharmacopsychiatry. 21: 155-67. PMID 6419061 DOI: 10.1159/000408491  1
1983 Nurnberger JI, Jimerson DC, Simmons-Alling S, Tamminga C, Nadi NS, Lawrence D, Sitaram N, Gillin JC, Gershon ES. Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and "well state" bipolar patients. Psychiatry Research. 9: 191-200. PMID 6312479 DOI: 10.1016/0165-1781(83)90043-4  1
1983 Durso R, Tamminga CA, Ruggeri S, Denaro A, Kuo S, Chase TN. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 46: 1134-7. PMID 6229607 DOI: 10.1136/Jnnp.46.12.1134  1
1983 Durso R, Tamminga CA, Denaro A, Ruggeri S, Chase TN. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease. Neurology. 33: 1229-32. PMID 6225034 DOI: 10.1212/Wnl.33.9.1299  1
1983 Foster NL, Chase TN, Denaro A, Hare TA, Tamminga CA. THIP treatment of Huntington's disease. Neurology. 33: 637-9. PMID 6221200 DOI: 10.1212/Wnl.33.5.637  1
1983 Tamminga CA, Thaker GK, Ferraro TN, Hare TA. GABA agonist treatment improves tardive dyskinesia. Lancet (London, England). 2: 97-8. PMID 6134975 DOI: 10.1016/S0140-6736(83)90075-2  1
1982 Durso R, Fedio P, Brouwers P, Cox C, Martin AJ, Ruggieri SA, Tamminga CA, Chase TN. Lysine vasopressin in Alzheimer disease. Neurology. 32: 674-7. PMID 7201100 DOI: 10.1212/Wnl.32.6.674  1
1982 Knight M, Plotkin C, Tamminga CA. Brain endopeptidase generates enkephalin from striatal precursors. Peptides. 3: 461-468. PMID 6750568 DOI: 10.1016/0196-9781(82)90108-5  1
1982 Tamminga CA, Carpenter WT. The DSM-III diagnosis of schizophrenic-like illness and the clinical pharmacology of psychosis Journal of Nervous and Mental Disease. 170: 744-751. PMID 6128375 DOI: 10.1097/00005053-198212000-00005  1
1981 Tamminga C. Endorphins in Mental Health Research Journal of Nervous and Mental Disease. 169: 398. DOI: 10.1097/00005053-198106000-00017  0.01
1981 Tamminga CA. Neuroendocrine Correlates in Neurology Journal of Nervous and Mental Disease. 169: 70. DOI: 10.1097/00005053-198101000-00016  0.01
1981 Tamminga CA, Schaffer MH. γ-Type Endorphins and Schizophrenia-Reply Archives of General Psychiatry. 38: 1182-1183. DOI: 10.1001/Archpsyc.1981.01780350116013  1
1979 Tamminga CA, Schaffer MH. Treatment of Schizophrenia with ergot derivatives. Psychopharmacology. 66: 239-242. PMID 119270 DOI: 10.1007/Bf00428312  1
1979 Smith RC, Tamminga CA, Crayton JW, Dekirmenjian H, Davis JM. Relationship of butaperazine blood levels to plasma prolactin in chronic schizophrenic patients. Psychopharmacology. 66: 29-33. PMID 44374 DOI: 10.1007/Bf00431985  1
1978 Tamminga CA, Schaffer MH, Smith RC, Davis JM. Schizophrenic symptoms improve with apomorphine Science. 200: 567-568. PMID 347574 DOI: 10.1126/Science.347574  1
1977 Tamminga CA, Smith RC, Pandey G, Frohman LA, Davis JM. A Neuroendocrine Study of Supersensitivity in Tardive Dyskinesia Archives of General Psychiatry. 34: 1199-1203. PMID 911219 DOI: 10.1001/Archpsyc.1977.01770220081009  1
1977 Tamminga CA, Smith RC, Ericksen SE, Chang S, Davis JM. Cholinergic influences in tardive dyskinesia American Journal of Psychiatry. 134: 769-774. PMID 869054 DOI: 10.1176/Ajp.134.7.769  1
1977 Smith RC, Tamminga CA, Haraszti J, Pandey GN, Davis JM. Effects of dopamine agonists in tardive dyskinesia. American Journal of Psychiatry. 134: 763-768. PMID 869053 DOI: 10.1176/Ajp.134.7.763  1
1977 Pandey GN, Garver DL, Tamminga CA, Ericksen S, Ali SI, Davis JM. Postsynaptic supersensitivity in schizophrenia American Journal of Psychiatry. 134: 518-522. PMID 848578 DOI: 10.1176/Ajp.134.5.518  1
1977 Smith RC, Tamminga C, Davis JM. Effect of apomorphine on schizophrenic symptoms. Journal of Neural Transmission. 40: 171-176. PMID 323423 DOI: 10.1007/Bf01250567  1
1977 Pandey GN, Garver DL, Tamminga CA, Davis JM. Dr. Pandey and Associates Reply American Journal of Psychiatry. 134. DOI: 10.1176/Ajp.134.10.1154-A  1
Show low-probability matches.